| GO ID | GO:0005886 |
| Ontology | CC |
| GO Term | plasma membrane |
| Definition | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ABCA1 | ATP binding cassette subfamily A member 1 |
19 | O95477 | chr9: 104,781,002-104,928,237 |
ABCA8 | ATP binding cassette subfamily A member 8 |
10351 | O94911 | chr17: 68,867,292-68,955,392 |
ABCB6 | ATP binding cassette subfamily B member 6 (Langereis blood group) |
10058 | Q9NP58 | chr2: 219,209,768-219,218,990 |
ABCC1 | ATP binding cassette subfamily C member 1 |
4363 | P33527 | chr16: 15,949,577-16,143,074 |
ABCC10 | ATP binding cassette subfamily C member 10 |
89845 | Q5T3U5 | chr6: 43,427,366-43,450,430 |
ABCC4 | ATP binding cassette subfamily C member 4 |
10257 | O15439 | chr13: 95,019,829-95,301,446 |
ABCC5 | ATP binding cassette subfamily C member 5 |
10057 | O15440 | chr3: 183,919,934-184,018,015 |
ABCG8 | ATP binding cassette subfamily G member 8 |
64241 | Q9H221 | chr2: 43,838,964-43,878,466 |
ABHD12 | abhydrolase domain containing 12 |
26090 | Q8N2K0 | chr20: 25,294,743-25,390,983 |
ABHD6 | abhydrolase domain containing 6 |
57406 | Q9BV23 | chr3: 58,237,506-58,295,693 |
ABR | active BCR-related |
29 | Q12979 | chr17: 1,003,518-1,229,021 |
ACE | angiotensin I converting enzyme |
1636 | P12821 | chr17: 63,477,061-63,498,380 |
ACKR4 | atypical chemokine receptor 4 |
51554 | Q9NPB9 | chr3: 132,597,237-132,618,967 |
ACOX1 | acyl-CoA oxidase 1, palmitoyl |
51 | Q15067 | chr17: 75,941,507-75,979,363 |
ACPP | acid phosphatase, prostate |
55 | P15309 | chr3: 132,317,367-132,368,298 |
ACSL1 | acyl-CoA synthetase long-chain family member 1 |
2180 | P33121 | chr4: 184,755,595-184,826,818 |
ACSL6 | Long-chain-fatty-acid--CoA ligase 6 |
23305 | Q9UKU0 | chr5: 131,949,973-132,012,243 |
ACTB | actin, beta |
60 | P60709 | chr7: 5,527,151-5,563,784 |
ACTG1 | actin gamma 1 |
71 | P63261 | chr17: 81,509,971-81,523,847 |
ACTL6A | actin like 6A |
86 | O96019 | chr3: 179,562,880-179,588,408 |
ACTN1 | actinin, alpha 1 |
87 | P12814 | chr14: 68,874,143-68,979,440 |
ACTN2 | actinin, alpha 2 |
88 | P35609 | chr1: 236,686,454-236,764,631 |
ACVR1B | activin A receptor type IB |
91 | P36896 | chr12: 51,951,667-51,997,078 |
ACVR2A | activin A receptor type IIA |
92 | P27037 | chr2: 147,844,517-147,930,826 |
ACVR2B | activin A receptor type IIB |
93 | Q13705 | chr3: 38,453,851-38,493,142 |
ADA | adenosine deaminase |
100 | P00813 | chr20: 44,619,522-44,652,233 |
ADAM10 | ADAM metallopeptidase domain 10 |
102 | O14672 | chr15: 58,588,807-58,749,978 |
ADAM12 | ADAM metallopeptidase domain 12 |
8038 | O43184 | chr10: 126,012,381-126,388,455 |
ADAM17 | ADAM metallopeptidase domain 17 |
6868 | P78536 | chr2: 9,488,486-9,555,792 |
ADAM21 | ADAM metallopeptidase domain 21 |
8747 | Q9UKJ8 | chr14: 70,452,157-70,459,899 |
ADAM23 | ADAM metallopeptidase domain 23 |
8745 | O75077 | chr2: 206,443,539-206,621,130 |
ADAM8 | ADAM metallopeptidase domain 8 |
101 | P78325 | chr10: 133,262,403-133,276,868 |
ADAP1 | ArfGAP with dual PH domains 1 |
11033 | O75689 | chr7: 897,901-955,407 |
ADAP2 | ArfGAP with dual PH domains 2 |
55803 | Q9NPF8 | chr17: 30,906,344-30,959,322 |
ADCY3 | adenylate cyclase 3 |
109 | O60266 | chr2: 24,819,169-24,919,839 |
ADCY7 | adenylate cyclase 7 |
113 | P51828 | chr16: 50,246,137-50,318,135 |
ADCY9 | adenylate cyclase 9 |
115 | O60503 | chr16: 3,953,387-4,116,185 |
ADCYAP1R1 | adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
117 | P41586 | chr7: 31,052,461-31,111,479 |
ADD3 | adducin 3 |
120 | Q9UEY8 | chr10: 109,996,368-110,135,565 |
ADGRD1 | adhesion G protein-coupled receptor D1 |
283383 | Q6QNK2 | chr12: 130,953,907-131,141,469 |
ADI1 | acireductone dioxygenase 1 |
55256 | Q9BV57 | chr2: 3,497,361-3,519,736 |
ADIPOR1 | adiponectin receptor 1 |
51094 | Q96A54 | chr1: 202,940,823-202,958,572 |
ADORA1 | adenosine A1 receptor |
134 | P30542 | chr1: 203,090,654-203,167,405 |
ADORA2B | adenosine A2b receptor |
136 | P29275 | chr17: 15,944,917-15,975,746 |
ADRA1A | adrenoceptor alpha 1A |
148 | P35348 | chr8: 26,748,150-26,867,273 |
ADRA1B | adrenoceptor alpha 1B |
147 | P35368 | chr5: 159,865,080-159,972,544 |
ADRA1D | adrenoceptor alpha 1D |
146 | P25100 | chr20: 4,220,631-4,249,074 |
ADRA2B | adrenoceptor alpha 2B |
151 | P18089 | chr2: 96,112,875-96,116,245 |
ADRB1 | adrenoceptor beta 1 |
153 | P08588 | chr10: 114,044,056-114,046,908 |
ADRB2 | adrenoceptor beta 2 |
154 | P07550 | chr5: 148,825,245-148,828,687 |
ADRB3 | adrenoceptor beta 3 |
155 | P13945 | chr8: 37,962,991-37,966,965 |
ADRBK2 | adrenergic, beta, receptor kinase 2 |
157 | P35626 | chr22: 25,564,849-25,729,294 |
ADRM1 | adhesion regulating molecule 1 |
11047 | Q16186 | chr20: 62,302,093-62,308,862 |
ADSS | adenylosuccinate synthase |
159 | P30520 | chr1: 244,408,494-244,452,134 |
AFAP1L2 | actin filament associated protein 1 like 2 |
84632 | Q8N4X5 | chr10: 114,294,824-114,404,756 |
AGPAT3 | 1-acylglycerol-3-phosphate O-acyltransferase 3 |
56894 | Q9NRZ7 | chr21: 43,865,186-43,986,536 |
AGTR1 | angiotensin II receptor, type 1 |
185 | P30556 | chr3: 148,697,784-148,743,008 |
AGTR2 | angiotensin II receptor, type 2 |
186 | P50052 | chrX: 116,170,722-116,174,972 |
AGTRAP | angiotensin II receptor-associated protein |
57085 | Q6RW13 | chr1: 11,736,084-11,754,802 |
AHNAK | AHNAK nucleoprotein |
79026 | Q09666 | chr11: 62,433,542-62,556,235 |
AIP | aryl hydrocarbon receptor interacting protein |
9049 | O00170 | chr11: 67,483,041-67,491,103 |
AJUBA | ajuba LIM protein |
84962 | Q96IF1 | chr14: 22,971,174-22,982,642 |
AK1 | adenylate kinase 1 |
203 | P00568 | chr9: 127,866,480-127,877,743 |
AKAP10 | A-kinase anchoring protein 10 |
11216 | O43572 | chr17: 19,904,302-19,978,343 |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
207 | P31749 | chr14: 104,769,349-104,795,751 |
AKT2 | v-akt murine thymoma viral oncogene homolog 2 |
208 | P31751 | chr19: 40,230,317-40,285,536 |
AKT3 | v-akt murine thymoma viral oncogene homolog 3 |
10000 | Q9Y243 | chr1: 243,488,233-243,851,079 |
AKTIP | AKT interacting protein |
64400 | Q9H8T0 | chr16: 53,491,040-53,504,411 |
ALG10B | ALG10B, alpha-1,2-glucosyltransferase |
144245 | Q5I7T1 | chr12: 38,316,578-38,329,728 |
ALOX15 | arachidonate 15-lipoxygenase |
246 | P16050 | chr17: 4,630,902-4,642,294 |
ALPL | alkaline phosphatase, liver/bone/kidney |
249 | P05186 | chr1: 21,509,372-21,578,412 |
AMBP | alpha-1-microglobulin/bikunin precursor |
259 | P02760 | chr9: 114,060,127-114,078,472 |
ANGPT1 | angiopoietin 1 |
284 | Q15389 | chr8: 107,249,482-107,498,055 |
ANGPT2 | angiopoietin 2 |
285 | O15123 | chr8: 6,499,651-6,563,409 |
ANK2 | ankyrin 2, neuronal |
287 | Q01484 | chr4: 112,818,109-113,383,740 |
ANK3 | ankyrin 3, node of Ranvier (ankyrin G) |
288 | Q12955 | chr10: 60,026,298-60,733,490 |
ANKH | ANKH inorganic pyrophosphate transport regulator |
56172 | Q9HCJ1 | chr5: 14,704,804-14,871,778 |
ANKRD11 | ankyrin repeat domain 11 |
29123 | Q6UB99 | chr16: 89,267,627-89,490,561 |
ANKRD13A | ankyrin repeat domain 13A |
88455 | Q8IZ07 | chr12: 109,999,186-110,039,763 |
ANKRD20A1 | ankyrin repeat domain 20 family member A1 |
84210 | Q5TYW2 | chr9: 67,859,147-67,902,094 |
ANKRD27 | ankyrin repeat domain 27 |
84079 | Q96NW4 | chr19: 32,597,007-32,676,597 |
ANO2 | anoctamin 2, calcium activated chloride channel |
57101 | Q9NQ90 | chr12: 5,531,869-5,946,232 |
ANO6 | anoctamin 6 |
196527 | Q4KMQ2 | chr12: 45,215,987-45,440,404 |
ANOS1 | anosmin 1 |
3730 | P23352 | chrX: 8,528,874-8,732,186 |
ANTXR2 | anthrax toxin receptor 2 |
118429 | P58335 | chr4: 79,901,149-80,125,454 |
ANXA1 | annexin A1 |
301 | P04083 | chr9: 73,151,757-73,170,393 |
ANXA2 | annexin A2 |
302 | P07355 | chr15: 60,347,134-60,402,883 |
ANXA3 | annexin A3 |
306 | P12429 | chr4: 78,551,519-78,610,451 |
ANXA4 | annexin A4 |
307 | P09525 | chr2: 69,644,425-69,827,100 |
AOC2 | amine oxidase, copper containing 2 |
314 | O75106 | chr17: 42,844,600-42,850,707 |
AOC3 | amine oxidase, copper containing 3 |
8639 | Q16853 | chr17: 42,851,184-42,858,130 |
AOPEP | aminopeptidase O |
84909 | Q8N6M6 | chr9: 94,726,701-95,087,218 |
AP2A2 | adaptor related protein complex 2, alpha 2 subunit |
161 | O94973 | chr11: 924,894-1,012,245 |
AP2B1 | adaptor related protein complex 2, beta 1 subunit |
163 | P63010 | chr17: 35,578,046-35,726,409 |
AP2M1 | adaptor related protein complex 2, mu 1 subunit |
1173 | Q96CW1 | chr3: 184,174,689-184,184,091 |
AP2S1 | adaptor related protein complex 2 sigma 1 subunit |
1175 | P53680 | chr19: 46,838,136-46,850,992 |
APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
322 | O00213 | chr11: 6,395,124-6,419,414 |
APC | adenomatous polyposis coli |
324 | P25054 | chr5: 112,707,498-112,846,239 |
APH1A | aph-1 homolog A, gamma secretase subunit |
51107 | Q96BI3 | chr1: 150,265,399-150,269,580 |
APH1B | aph-1 homolog B, gamma secretase subunit |
83464 | Q8WW43 | chr15: 63,276,018-63,309,126 |
APLP2 | amyloid beta (A4) precursor-like protein 2 |
334 | Q06481 | chr11: 130,069,837-130,144,811 |
APOA1 | apolipoprotein A-I |
335 | P02647 | chr11: 116,835,751-116,837,950 |
APOB | apolipoprotein B |
338 | P04114 | chr2: 21,001,429-21,044,073 |
APOBR | apolipoprotein B receptor |
55911 | Q0VD83 | chr16: 28,494,649-28,498,970 |
APOE | apolipoprotein E |
348 | P02649 | chr19: 44,905,754-44,909,393 |
APOLD1 | apolipoprotein L domain containing 1 |
81575 | Q96LR9 | chr12: 12,725,917-12,829,975 |
APP | amyloid beta (A4) precursor protein |
351 | P05067 | chr21: 25,880,550-26,171,128 |
AQP2 | aquaporin 2 (collecting duct) |
359 | P41181 | chr12: 49,950,741-49,958,881 |
AQP3 | aquaporin 3 (Gill blood group) |
360 | Q92482 | chr9: 33,441,154-33,447,611 |
AQP8 | aquaporin 8 |
343 | O94778 | chr16: 25,215,731-25,228,940 |
AQP9 | aquaporin 9 |
366 | O43315 | chr15: 58,138,169-58,185,911 |
AR | androgen receptor |
367 | P10275 | chrX: 67,544,032-67,730,619 |
ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
116985 | Q96P48 | chr11: 72,685,069-72,793,599 |
ARAP3 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
64411 | Q8WWN8 | chr5: 141,653,401-141,682,221 |
ARC | activity-regulated cytoskeleton-associated protein |
23237 | Q7LC44 | chr8: 142,611,044-142,614,472 |
ARF1 | ADP ribosylation factor 1 |
375 | P84077 | chr1: 228,082,660-228,099,212 |
ARF5 | ADP ribosylation factor 5 |
381 | P84085 | chr7: 127,588,345-127,591,705 |
ARFGAP2 | ADP ribosylation factor GTPase activating protein 2 |
84364 | Q8N6H7 | chr11: 47,164,299-47,177,125 |
ARHGAP33 | Rho GTPase activating protein 33 |
115703 | O14559 | chr19: 35,774,532-35,788,822 |
ARHGEF28 | Rho guanine nucleotide exchange factor 28 |
64283 | Q8N1W1 | chr5: 73,626,158-73,941,993 |
ARHGEF39 | Rho guanine nucleotide exchange factor 39 |
84904 | Q8N4T4 | chr9: 35,658,875-35,675,866 |
ARHGEF5 | Rho guanine nucleotide exchange factor 5 |
7984 | Q12774 | chr7: 144,355,288-144,380,632 |
ARHGEF7 | Rho guanine nucleotide exchange factor 7 |
8874 | Q14155 | chr13: 111,114,559-111,305,737 |
ARL4D | ADP ribosylation factor like GTPase 4D |
379 | P49703 | chr17: 43,398,959-43,401,137 |
ARL6IP5 | ADP ribosylation factor like GTPase 6 interacting protein 5 |
10550 | O75915 | chr3: 69,084,944-69,106,066 |
ARRDC1 | arrestin domain containing 1 |
92714 | Q8N5I2 | chr9: 137,605,654-137,615,360 |
ARRDC3 | arrestin domain containing 3 |
57561 | Q96B67 | chr5: 91,368,724-91,383,359 |
ARRDC4 | arrestin domain containing 4 |
91947 | Q8NCT1 | chr15: 97,960,698-97,973,838 |
ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
8853 | O43150 | chr2: 9,206,765-9,405,683 |
ASIC2 | acid sensing ion channel subunit 2 |
40 | Q16515 | chr17: 33,013,087-34,174,964 |
ASIC3 | acid sensing ion channel subunit 3 |
9311 | Q9UHC3 | chr7: 151,048,292-151,052,756 |
ASPH | aspartate beta-hydroxylase |
444 | Q12797 | chr8: 61,500,556-61,714,640 |
ASPSCR1 | alveolar soft part sarcoma chromosome region, candidate 1 |
79058 | Q9BZE9 | chr17: 81,976,807-82,017,406 |
ATP11B | ATPase, class VI, type 11B |
23200 | Q9Y2G3 | chr3: 182,793,500-182,921,635 |
ATP12A | ATPase, H+/K+ transporting, nongastric, alpha polypeptide |
479 | P54707 | chr13: 24,680,411-24,712,493 |
ATP13A5 | ATPase type 13A5 |
344905 | Q4VNC0 | chr3: 193,274,790-193,378,843 |
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide |
477 | P50993 | chr1: 160,115,759-160,143,591 |
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide |
481 | P05026 | chr1: 169,105,697-169,132,722 |
ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide |
483 | P54709 | chr3: 141,876,124-141,926,514 |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 |
490 | P20020 | chr12: 89,588,049-89,709,300 |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 |
493 | P23634 | chr1: 203,626,561-203,744,081 |
ATP5O | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
539 | P48047 | chr21: 33,903,453-33,915,980 |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 |
535 | Q93050 | chr17: 42,458,844-42,522,611 |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 |
526 | P21281 | chr8: 20,197,367-20,226,819 |
ATP6V1C1 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 |
528 | P21283 | chr8: 103,021,063-103,073,051 |
ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 |
9550 | O75348 | chr9: 114,587,746-114,598,373 |
ATP6V1H | ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H |
51606 | Q9UI12 | chr8: 53,715,557-53,843,558 |
ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
5205 | O43520 | chr18: 57,646,426-57,803,101 |
ATP8B4 | ATPase, class I, type 8B, member 4 |
79895 | Q8TF62 | chr15: 49,858,238-50,182,817 |
ATP9A | ATPase, class II, type 9A |
10079 | O75110 | chr20: 51,596,514-51,768,634 |
ATXN10 | ataxin 10 |
25814 | Q9UBB4 | chr22: 45,671,798-45,845,307 |
AVPR2 | arginine vasopressin receptor 2 |
554 | P30518 | chrX: 153,902,531-153,907,166 |
AZGP1 | alpha-2-glycoprotein 1, zinc-binding |
563 | P25311 | chr7: 99,966,720-99,976,157 |
B2M | beta-2-microglobulin |
567 | P61769 | chr15: 44,711,477-44,718,877 |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
2683 | P15291 | chr9: 33,104,082-33,167,356 |
BAIAP2L1 | BAI1-associated protein 2-like 1 |
55971 | Q9UHR4 | chr7: 98,291,651-98,401,068 |
BAMBI | BMP and activin membrane-bound inhibitor |
25805 | Q13145 | chr10: 28,677,342-28,682,939 |
BCAM | basal cell adhesion molecule (Lutheran blood group) |
4059 | P50895 | chr19: 44,809,059-44,821,420 |
BCL10 | B-cell CLL/lymphoma 10 |
8915 | O95999 | chr1: 85,266,248-85,277,090 |
BCORL1 | BCL6 corepressor-like 1 |
63035 | Q5H9F3 | chrX: 129,981,107-130,058,083 |
BEST1 | bestrophin 1 |
7439 | O76090 | chr11: 61,949,821-61,965,515 |
BICD2 | bicaudal D homolog 2 (Drosophila) |
23299 | Q8TD16 | chr9: 92,711,363-92,764,812 |
BLNK | B-cell linker |
29760 | Q8WV28 | chr10: 96,191,702-96,271,587 |
BLVRB | biliverdin reductase B |
645 | P30043 | chr19: 40,447,789-40,465,840 |
BMPR1A | bone morphogenetic protein receptor type IA |
657 | P36894 | chr10: 86,756,601-86,932,838 |
BMPR2 | bone morphogenetic protein receptor type II |
659 | Q13873 | chr2: 202,376,936-202,567,751 |
BNC2 | basonuclin 2 |
54796 | Q6ZN30 | chr9: 16,409,503-16,870,843 |
BRCA1 | breast cancer 1 |
672 | P38398 | chr17: 43,044,295-43,170,245 |
BSG | basigin (Ok blood group) |
682 | P35613 | chr19: 571,277-583,493 |
BST2 | bone marrow stromal cell antigen 2 |
684 | Q10589 | chr19: 17,402,939-17,405,648 |
BTC | betacellulin |
685 | P35070 | chr4: 74,744,759-74,794,686 |
BTN3A2 | butyrophilin subfamily 3 member A2 |
11118 | P78410 | chr6: 26,365,159-26,378,320 |
BTN3A3 | butyrophilin subfamily 3 member A3 |
10384 | O00478 | chr6: 26,440,472-26,453,415 |
BVES | blood vessel epicardial substance |
11149 | Q8NE79 | chr6: 105,096,822-105,137,174 |
C10orf54 | chromosome 10 open reading frame 54 |
64115 | Q9H7M9 | chr10: 71,747,559-71,773,498 |
C11orf24 | chromosome 11 open reading frame 24 |
53838 | Q96F05 | chr11: 68,261,335-68,272,001 |
C1QBP | complement component 1, q subcomponent binding protein |
708 | Q07021 | chr17: 5,432,777-5,448,830 |
C21orf2 | chromosome 21 open reading frame 2 |
755 | O43822 | chr21: 44,328,944-44,339,402 |
C2CD5 | C2 calcium-dependent domain containing 5 |
9847 | Q86YS7 | chr12: 22,448,583-22,544,546 |
C3 | complement component 3 |
718 | P01024 | chr19: 6,677,704-6,730,562 |
C4A | complement component 4A (Rodgers blood group) |
720 | P0C0L4 | chr6: 31,982,024-32,002,681 |
C4B | complement component 4B (Chido blood group) |
721 | P0C0L5 | chr6: 32,014,762-32,035,418 |
C5AR1 | complement component 5a receptor 1 |
728 | P21730 | chr19: 47,290,023-47,322,066 |
C6orf89 | chromosome 6 open reading frame 89 |
221477 | Q6UWU4 | chr6: 36,871,870-36,928,964 |
C8orf37 | chromosome 8 open reading frame 37 |
157657 | Q96NL8 | chr8: 95,244,919-95,269,201 |
CA12 | carbonic anhydrase XII |
771 | O43570 | chr15: 63,321,378-63,382,161 |
CA2 | carbonic anhydrase II |
760 | P00918 | chr8: 85,463,852-85,481,493 |
CA4 | carbonic anhydrase IV |
762 | P22748 | chr17: 60,149,936-60,170,899 |
CACNA1C | calcium channel, voltage-dependent, L type, alpha 1C subunit |
775 | Q13936 | chr12: 1,970,786-2,697,950 |
CACNA1E | calcium channel, voltage-dependent, R type, alpha 1E subunit |
777 | Q15878 | chr1: 181,413,102-181,808,084 |
CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit |
8913 | O43497 | chr17: 50,561,068-50,627,474 |
CACNA2D1 | calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
781 | P54289 | chr7: 81,946,444-82,443,798 |
CACNB3 | calcium channel, voltage-dependent, beta 3 subunit |
784 | P54284 | chr12: 48,813,794-48,828,941 |
CACNG6 | calcium channel, voltage-dependent, gamma subunit 6 |
59285 | Q9BXT2 | chr19: 53,992,288-54,012,669 |
CACNG8 | calcium channel, voltage-dependent, gamma subunit 8 |
59283 | Q8WXS5 | chr19: 53,963,040-53,990,215 |
CADM1 | cell adhesion molecule 1 |
23705 | Q9BY67 | chr11: 115,169,218-115,504,957 |
CALD1 | caldesmon 1 |
800 | Q05682 | chr7: 134,744,252-134,970,728 |
CALM2 | calmodulin 2 |
805 | P62158 | chr2: 47,160,082-47,176,601 |
CAMK2D | calcium/calmodulin-dependent protein kinase II delta |
817 | Q13557 | chr4: 113,451,032-113,761,927 |
CAPN10 | calpain 10 |
11132 | Q9HC96 | chr2: 240,586,716-240,617,705 |
CAPN3 | calpain 3 |
825 | P20807 | chr15: 42,359,500-42,412,318 |
CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
8573 | O14936 | chrX: 41,514,934-41,923,463 |
CAV1 | caveolin 1 |
857 | Q03135 | chr7: 116,524,785-116,561,184 |
CAV2 | caveolin 2 |
858 | P51636 | chr7: 116,287,380-116,508,541 |
CBLB | Cbl proto-oncogene B, E3 ubiquitin protein ligase |
868 | Q13191 | chr3: 105,655,461-105,869,552 |
CCDC8 | coiled-coil domain containing 8 |
83987 | Q9H0W5 | chr19: 46,410,372-46,413,584 |
CCDC88A | coiled-coil domain containing 88A |
55704 | Q3V6T2 | chr2: 55,287,842-55,419,921 |
CCKBR | cholecystokinin B receptor |
887 | P32239 | chr11: 6,259,736-6,272,127 |
CCND3 | cyclin D3 |
896 | P30281 | chr6: 41,934,933-42,050,357 |
CCT3 | chaperonin containing TCP1, subunit 3 (gamma) |
7203 | P49368 | chr1: 156,308,968-156,367,873 |
CD14 | CD14 molecule |
929 | P08571 | chr5: 140,631,728-140,633,701 |
CD151 | CD151 molecule (Raph blood group) |
977 | P48509 | chr11: 832,843-839,831 |
CD163 | CD163 molecule |
9332 | Q86VB7 | chr12: 7,470,813-7,503,893 |
CD163L1 | CD163 molecule like 1 |
283316 | Q9NR16 | chr12: 7,346,685-7,479,897 |
CD164 | CD164 molecule, sialomucin |
8763 | Q04900 | chr6: 109,366,514-109,382,457 |
CD177 | CD177 molecule |
57126 | Q8N6Q3 | chr19: 43,353,659-43,363,172 |
CD1D | CD1d molecule |
912 | P15813 | chr1: 158,179,947-158,184,896 |
CD200 | CD200 molecule |
4345 | P41217 | chr3: 112,332,347-112,362,812 |
CD209 | CD209 molecule |
30835 | Q9NNX6 | chr19: 7,739,994-7,747,564 |
CD244 | CD244 molecule, natural killer cell receptor 2B4 |
51744 | Q9BZW8 | chr1: 160,830,160-160,862,855 |
CD27 | CD27 molecule |
939 | P26842 | chr12: 6,444,867-6,451,718 |
CD28 | CD28 molecule |
940 | P10747 | chr2: 203,706,475-203,738,912 |
CD320 | CD320 molecule |
51293 | Q9NPF0 | chr19: 8,302,127-8,308,356 |
CD33 | CD33 molecule |
945 | P20138 | chr19: 51,225,064-51,243,860 |
CD36 | CD36 molecule (thrombospondin receptor) |
948 | P16671 | chr7: 80,369,575-80,679,277 |
CD4 | CD4 molecule |
920 | P01730 | chr12: 6,786,858-6,820,808 |
CD40LG | CD40 ligand |
959 | P29965 | chrX: 136,648,193-136,660,390 |
CD44 | CD44 molecule (Indian blood group) |
960 | P16070 | chr11: 35,138,870-35,232,402 |
CD46 | CD46 molecule, complement regulatory protein |
4179 | P15529 | chr1: 207,752,057-207,795,513 |
CD47 | CD47 molecule |
961 | Q08722 | chr3: 108,043,298-108,091,025 |
CD48 | CD48 molecule |
962 | P09326 | chr1: 160,678,746-160,711,851 |
CD53 | CD53 molecule |
963 | P19397 | chr1: 110,873,154-110,899,928 |
CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
1604 | P08174 | chr1: 207,321,508-207,386,804 |
CD58 | CD58 molecule |
965 | P19256 | chr1: 116,514,535-116,571,039 |
CD68 | CD68 molecule |
968 | P34810 | chr17: 7,579,467-7,582,113 |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain |
972 | P04233 | chr5: 150,401,637-150,412,929 |
CD81 | CD81 molecule |
975 | P60033 | chr11: 2,376,177-2,397,419 |
CD83 | CD83 molecule |
9308 | Q01151 | chr6: 14,117,256-14,136,918 |
CD9 | CD9 molecule |
928 | P21926 | chr12: 6,199,715-6,238,271 |
CD93 | CD93 molecule |
22918 | Q9NPY3 | chr20: 23,079,349-23,086,340 |
CD97 | adhesion G protein-coupled receptor E5 |
976 | P48960 | chr19: 14,380,501-14,408,725 |
CD99 | CD99 molecule |
4267 | P14209 | chrX: 2,691,179-2,741,309 |
CDC42 | cell division cycle 42 |
998 | P60953 | chr1: 22,052,627-22,092,946 |
CDC42BPB | CDC42 binding protein kinase beta (DMPK-like) |
9578 | Q9Y5S2 | chr14: 102,932,379-103,057,462 |
CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 |
10602 | Q9UKI2 | chr2: 37,641,882-37,738,468 |
CDC42SE1 | CDC42 small effector 1 |
56882 | Q9NRR8 | chr1: 151,050,971-151,070,325 |
CDC42SE2 | CDC42 small effector 2 |
56990 | Q9NRR3 | chr5: 131,245,493-131,398,447 |
CDCA5 | cell division cycle associated 5 |
113130 | Q96FF9 | chr11: 65,066,300-65,084,164 |
CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) |
1009 | P55287 | chr16: 64,943,753-65,126,112 |
CDH12 | cadherin 12, type 2 (N-cadherin 2) |
1010 | P55289 | chr5: 21,750,673-22,853,622 |
CDH13 | cadherin 13 |
1012 | P55290 | chr16: 82,626,803-83,800,640 |
CDH15 | cadherin 15, type 1, M-cadherin (myotubule) |
1013 | P55291 | chr16: 89,171,767-89,195,492 |
CDH17 | cadherin 17, LI cadherin (liver-intestine) |
1015 | Q12864 | chr8: 94,127,171-94,217,303 |
CDH2 | cadherin 2, type 1, N-cadherin (neuronal) |
1000 | P19022 | chr18: 27,950,966-28,177,446 |
CDH22 | cadherin 22, type 2 |
64405 | Q9UJ99 | chr20: 46,173,733-46,308,498 |
CDH5 | cadherin 5, type 2 (vascular endothelium) |
1003 | P33151 | chr16: 66,366,622-66,404,786 |
CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) |
1004 | P55285 | chr5: 31,193,750-31,329,146 |
CDK16 | cyclin-dependent kinase 16 |
5127 | Q00536 | chrX: 47,217,860-47,229,997 |
CDK5 | cyclin-dependent kinase 5 |
1020 | Q00535 | chr7: 151,053,812-151,058,530 |
CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 |
1087 | Q14002 | chr19: 41,673,307-41,706,976 |
CELSR3 | cadherin, EGF LAG seven-pass G-type receptor 3 |
1951 | Q9NYQ7 | chr3: 48,636,469-48,662,915 |
CEMIP | cell migration inducing protein, hyaluronan binding |
57214 | Q8WUJ3 | chr15: 80,779,343-80,951,776 |
CEP89 | centrosomal protein 89kDa |
84902 | Q96ST8 | chr19: 32,875,925-32,971,991 |
CFB | complement factor B |
629 | P00751 | chr6: 31,945,650-31,952,084 |
CFTR | cystic fibrosis transmembrane conductance regulator |
1080 | P13569 | chr7: 117,465,784-117,715,971 |
CHD1L | chromodomain helicase DNA binding protein 1-like |
9557 | Q86WJ1 | chr1: 147,242,641-147,295,766 |
CHD9 | chromodomain helicase DNA binding protein 9 |
80205 | Q3L8U1 | chr16: 53,055,033-53,329,150 |
CHIC1 | cysteine rich hydrophobic domain 1 |
53344 | Q5VXU3 | chrX: 73,563,200-73,687,102 |
CHL1 | cell adhesion molecule L1-like |
10752 | O00533 | chr3: 196,596-409,417 |
CHP1 | calcineurin-like EF-hand protein 1 |
11261 | Q99653 | chr15: 41,230,839-41,281,890 |
CHRM2 | cholinergic receptor, muscarinic 2 |
1129 | P08172 | chr7: 136,868,669-137,020,255 |
CHRM3 | cholinergic receptor, muscarinic 3 |
1131 | P20309 | chr1: 239,386,565-239,915,452 |
CHRNA5 | cholinergic receptor, nicotinic alpha 5 |
1138 | P30532 | chr15: 78,565,520-78,595,269 |
CHRNA7 | cholinergic receptor, nicotinic alpha 7 |
1139 | P36544 | chr15: 31,923,438-32,173,018 |
CIB1 | calcium and integrin binding 1 |
10519 | Q99828 | chr15: 90,229,975-90,234,047 |
CLCA4 | chloride channel accessory 4 |
22802 | Q14CN2 | chr1: 86,547,078-86,580,754 |
CLCN3 | chloride channel, voltage-sensitive 3 |
1182 | P51790 | chr4: 169,612,633-169,723,673 |
CLCNKA | chloride channel, voltage-sensitive Ka |
1187 | P51800 | chr1: 16,018,875-16,034,050 |
CLCNKB | chloride channel, voltage-sensitive Kb |
1188 | P51801 | chr1: 16,043,736-16,057,308 |
CLDN4 | claudin 4 |
1364 | O14493 | chr7: 73,799,542-73,832,693 |
CLEC2B | C-type lectin domain family 2 member B |
9976 | Q92478 | chr12: 9,852,984-9,870,136 |
CLEC4D | C-type lectin domain family 4 member D |
338339 | Q8WXI8 | chr12: 8,509,475-8,522,366 |
CLEC7A | C-type lectin domain family 7 member A |
64581 | Q9BXN2 | chr12: 10,116,777-10,130,258 |
CLIC1 | chloride intracellular channel 1 |
1192 | O00299 | chr6: 31,730,581-31,739,763 |
CLIC6 | chloride intracellular channel 6 |
54102 | Q96NY7 | chr21: 34,669,389-34,718,227 |
CLN3 | ceroid-lipofuscinosis, neuronal 3 |
1201 | Q13286 | chr16: 28,474,111-28,495,575 |
CLTA | clathrin, light chain A |
1211 | P09496 | chr9: 36,190,856-36,304,781 |
CNGA1 | cyclic nucleotide gated channel alpha 1 |
1259 | P29973 | chr4: 47,935,977-48,016,672 |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase |
1267 | P09543 | chr17: 41,966,741-41,977,731 |
CNR1 | cannabinoid receptor 1 (brain) |
1268 | P21554 | chr6: 88,139,864-88,166,359 |
CNST | consortin, connexin sorting protein |
163882 | Q6PJW8 | chr1: 246,566,444-246,668,584 |
CNTN1 | contactin 1 |
1272 | Q12860 | chr12: 40,692,442-41,072,418 |
CNTN3 | contactin 3 |
5067 | Q9P232 | chr3: 74,262,568-74,521,140 |
CNTN4 | contactin 4 |
152330 | Q8IWV2 | chr3: 2,098,813-3,057,956 |
COBL | cordon-bleu WH2 repeat protein |
23242 | O75128 | chr7: 51,016,212-51,316,818 |
COL13A1 | collagen, type XIII, alpha 1 |
1305 | Q5TAT6 | chr10: 69,801,931-69,964,275 |
COL17A1 | collagen, type XVII, alpha 1 |
1308 | Q9UMD9 | chr10: 104,031,286-104,086,002 |
COL23A1 | collagen, type XXIII, alpha 1 |
91522 | Q86Y22 | chr5: 178,237,618-178,590,555 |
COLEC12 | collectin subfamily member 12 |
81035 | Q5KU26 | chr18: 316,740-500,722 |
COLQ | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
8292 | Q9Y215 | chr3: 15,450,133-15,521,751 |
COMT | catechol-O-methyltransferase |
1312 | P21964 | chr22: 19,941,607-19,969,975 |
CORO1A | coronin, actin binding protein, 1A |
11151 | P31146 | chr16: 30,182,827-30,189,076 |
CORO1B | coronin, actin binding protein, 1B |
57175 | Q9BR76 | chr11: 67,435,510-67,443,821 |
CPAMD8 | C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
27151 | Q8IZJ3 | chr19: 16,892,947-17,026,815 |
CPE | carboxypeptidase E |
1363 | P16870 | chr4: 165,361,194-165,498,320 |
CPM | carboxypeptidase M |
1368 | P14384 | chr12: 68,842,197-68,971,570 |
CPNE2 | copine II |
221184 | Q96FN4 | chr16: 57,092,537-57,148,367 |
CPPED1 | calcineurin-like phosphoesterase domain containing 1 |
55313 | Q9BRF8 | chr16: 12,659,799-12,804,017 |
CR1 | complement component (3b/4b) receptor 1 (Knops blood group) |
1378 | P17927 | chr1: 207,496,147-207,640,647 |
CRCP | CGRP receptor component |
27297 | O75575 | chr7: 66,114,604-66,154,568 |
CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) |
51232 | Q9NZV1 | chr2: 36,355,926-36,551,135 |
CRIPAK | cysteine-rich PAK1 inhibitor |
285464 | Q8N1N5 | chr4: 1,347,266-1,395,992 |
CRLF3 | cytokine receptor-like factor 3 |
51379 | Q8IUI8 | chr17: 30,769,388-30,824,776 |
CROCC | ciliary rootlet coiled-coil, rootletin |
9696 | Q5TZA2 | chr1: 16,740,273-16,972,979 |
CRYL1 | crystallin lambda 1 |
51084 | Q9Y2S2 | chr13: 20,403,667-20,525,857 |
CSF1R | colony stimulating factor 1 receptor |
1436 | P07333 | chr5: 150,053,291-150,113,372 |
CSF3R | colony stimulating factor 3 receptor |
1441 | Q99062 | chr1: 36,466,043-36,483,278 |
CSK | c-src tyrosine kinase |
1445 | P41240 | chr15: 74,782,057-74,803,198 |
CSNK1D | casein kinase 1, delta |
1453 | P48730 | chr17: 82,239,023-82,273,731 |
CTGF | connective tissue growth factor |
1490 | P29279 | chr6: 131,948,176-131,951,373 |
CTNNA1 | catenin alpha 1 |
1495 | P35221 | chr5: 138,610,967-138,935,034 |
CTNNAL1 | catenin alpha-like 1 |
8727 | Q9UBT7 | chr9: 108,942,569-109,013,529 |
CTNNB1 | catenin beta 1 |
1499 | P35222 | chr3: 41,194,837-41,260,096 |
CTNND1 | catenin delta 1 |
1500 | O60716 | chr11: 57,753,243-57,819,546 |
CTSZ | cathepsin Z |
1522 | Q9UBR2 | chr20: 58,995,185-59,007,247 |
CTTN | cortactin |
2017 | Q14247 | chr11: 70,398,404-70,436,584 |
CXADR | coxsackie virus and adenovirus receptor |
1525 | P78310 | chr21: 17,512,382-17,593,579 |
CXCL16 | chemokine (C-X-C motif) ligand 16 |
58191 | Q9H2A7 | chr17: 4,733,526-4,739,922 |
CXCR2 | chemokine (C-X-C motif) receptor 2 |
3579 | P25025 | chr2: 218,125,289-218,137,253 |
CXCR4 | chemokine (C-X-C motif) receptor 4 |
7852 | P61073 | chr2: 136,114,349-136,118,165 |
CYBB | cytochrome b-245, beta polypeptide |
1536 | P04839 | chrX: 37,780,011-37,813,461 |
CYBRD1 | cytochrome b reductase 1 |
79901 | Q53TN4 | chr2: 171,522,247-171,558,133 |
CYP2W1 | cytochrome P450 family 2 subfamily W member 1 |
54905 | Q8TAV3 | chr7: 983,199-989,640 |
CYP51A1 | cytochrome P450 family 51 subfamily A member 1 |
1595 | Q16850 | chr7: 92,112,151-92,142,952 |
CYSTM1 | cysteine-rich transmembrane module containing 1 |
84418 | Q9H1C7 | chr5: 140,174,642-140,282,052 |
CYTH3 | cytohesin 3 |
9265 | O43739 | chr7: 6,161,776-6,272,644 |
DAAM1 | dishevelled associated activator of morphogenesis 1 |
23002 | Q9Y4D1 | chr14: 59,188,646-59,371,405 |
DAB2 | Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
1601 | P98082 | chr5: 39,371,675-39,462,300 |
DAG1 | dystroglycan 1 |
1605 | Q14118 | chr3: 49,468,703-49,535,618 |
DAGLB | diacylglycerol lipase, beta |
221955 | Q8NCG7 | chr7: 6,409,126-6,484,190 |
DAPK1 | death-associated protein kinase 1 |
1612 | P53355 | chr9: 87,497,228-87,708,633 |
DBN1 | drebrin 1 |
1627 | Q16643 | chr5: 177,456,608-177,474,401 |
DCXR | dicarbonyl/L-xylulose reductase |
51181 | Q7Z4W1 | chr17: 82,035,136-82,037,732 |
DDR1 | discoidin domain receptor tyrosine kinase 1 |
780 | Q08345 | chr6: 30,876,421-30,900,156 |
DEF6 | DEF6, guanine nucleotide exchange factor |
50619 | Q9H4E7 | chr6: 35,297,852-35,321,771 |
DENND4C | DENN/MADD domain containing 4C |
55667 | Q5VZ89 | chr9: 19,230,435-19,373,545 |
DGKH | diacylglycerol kinase, eta |
160851 | Q86XP1 | chr13: 42,040,036-42,256,578 |
DGKK | diacylglycerol kinase, kappa |
139189 | Q5KSL6 | chrX: 50,365,409-50,470,738 |
DGKZ | diacylglycerol kinase, zeta |
8525 | Q13574 | chr11: 46,332,905-46,380,554 |
DHH | desert hedgehog |
50846 | O43323 | chr12: 49,089,421-49,094,819 |
DIO2 | deiodinase, iodothyronine, type II |
1734 | Q92813 | chr14: 80,197,527-80,387,757 |
DIRAS3 | DIRAS family, GTP-binding RAS-like 3 |
9077 | O95661 | chr1: 68,045,962-68,051,631 |
DKK1 | dickkopf WNT signaling pathway inhibitor 1 |
22943 | O94907 | chr10: 52,314,296-52,318,042 |
DLG1 | discs, large homolog 1 (Drosophila) |
1739 | Q12959 | chr3: 197,042,560-197,299,300 |
DLG4 | discs, large homolog 4 (Drosophila) |
1742 | P78352 | chr17: 7,189,890-7,219,702 |
DLG5 | discs, large homolog 5 (Drosophila) |
9231 | Q8TDM6 | chr10: 77,790,791-77,926,526 |
DLL4 | delta-like 4 (Drosophila) |
54567 | Q9NR61 | chr15: 40,929,340-40,939,072 |
DMPK | dystrophia myotonica protein kinase |
1760 | Q09013 | chr19: 45,769,717-45,782,552 |
DNAJB4 | DnaJ heat shock protein family (Hsp40) member B4 |
11080 | Q9UDY4 | chr1: 77,979,175-78,017,964 |
DNAJC1 | DnaJ heat shock protein family (Hsp40) member C1 |
64215 | Q96KC8 | chr10: 21,756,537-22,003,769 |
DNAJC9 | DnaJ heat shock protein family (Hsp40) member C9 |
23234 | Q8WXX5 | chr10: 73,183,362-73,248,862 |
DNAL4 | dynein, axonemal, light chain 4 |
10126 | O96015 | chr22: 38,778,508-38,794,198 |
DNER | delta/notch like EGF repeat containing |
92737 | Q8NFT8 | chr2: 229,357,629-229,714,558 |
DOCK5 | dedicator of cytokinesis 5 |
80005 | Q9H7D0 | chr8: 25,184,723-25,418,082 |
DPP4 | dipeptidyl-peptidase 4 |
1803 | P27487 | chr2: 161,992,241-162,074,542 |
DPP6 | dipeptidyl-peptidase 6 |
1804 | P42658 | chr7: 153,887,097-154,894,285 |
DRD2 | dopamine receptor D2 |
1813 | P14416 | chr11: 113,409,615-113,475,691 |
DSC2 | desmocollin 2 |
1824 | Q02487 | chr18: 31,058,840-31,102,415 |
DSG2 | desmoglein 2 |
1829 | Q14126 | chr18: 31,498,043-31,549,008 |
DSP | desmoplakin |
1832 | P15924 | chr6: 7,541,575-7,586,717 |
DUOX1 | dual oxidase 1 |
53905 | Q9NRD9 | chr15: 45,129,933-45,165,576 |
DUOX2 | dual oxidase 2 |
50506 | Q9NRD8 | chr15: 45,092,650-45,114,344 |
DUOXA1 | dual oxidase maturation factor 1 |
90527 | Q1HG43 | chr15: 45,117,367-45,129,938 |
DXO | decapping exoribonuclease |
1797 | O77932 | chr6: 31,969,810-31,972,292 |
DYNLL1 | dynein, light chain, LC8-type 1 |
8655 | P63167 | chr12: 120,469,850-120,498,493 |
EDNRA | endothelin receptor type A |
1909 | P25101 | chr4: 147,480,917-147,544,954 |
EEF2 | eukaryotic translation elongation factor 2 |
1938 | P13639 | chr19: 3,976,056-3,985,469 |
EFNA1 | ephrin-A1 |
1942 | P20827 | chr1: 155,127,460-155,134,857 |
EFNA4 | ephrin-A4 |
1945 | P52798 | chr1: 155,063,731-155,069,553 |
EFNA5 | ephrin-A5 |
1946 | P52803 | chr5: 107,376,889-107,670,895 |
EFNB2 | ephrin-B2 |
1948 | P52799 | chr13: 106,489,731-106,535,114 |
EGFR | epidermal growth factor receptor |
1956 | P00533 | chr7: 55,019,021-55,211,628 |
EHD4 | EH domain containing 4 |
30844 | Q9H223 | chr15: 41,895,939-41,972,578 |
EIF2B1 | eukaryotic translation initiation factor 2B subunit alpha |
1967 | Q14232 | chr12: 123,620,406-123,633,766 |
EIF5 | eukaryotic translation initiation factor 5 |
1983 | P55010 | chr14: 103,333,544-103,345,025 |
ELMO1 | engulfment and cell motility 1 |
9844 | Q92556 | chr7: 36,854,361-37,449,249 |
EMP1 | epithelial membrane protein 1 |
2012 | P54849 | chr12: 13,196,716-13,219,939 |
EMP2 | epithelial membrane protein 2 |
2013 | P54851 | chr16: 10,528,422-10,580,698 |
EMP3 | epithelial membrane protein 3 |
2014 | P54852 | chr19: 48,321,509-48,330,553 |
ENAH | enabled homolog (Drosophila) |
55740 | Q8N8S7 | chr1: 225,486,835-225,653,142 |
ENO1 | enolase 1, (alpha) |
2023 | P06733 | chr1: 8,861,002-8,879,249 |
ENO2 | enolase 2 (gamma, neuronal) |
2026 | P09104 | chr12: 6,913,745-6,923,698 |
ENO3 | enolase 3 (beta, muscle) |
2027 | P13929 | chr17: 4,948,092-4,957,131 |
ENOX1 | ecto-NOX disulfide-thiol exchanger 1 |
55068 | Q8TC92 | chr13: 43,213,518-43,786,908 |
ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
5167 | P22413 | chr6: 131,808,016-131,895,155 |
ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
5168 | Q13822 | chr8: 119,557,086-119,673,453 |
ENPP4 | ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) |
22875 | Q9Y6X5 | chr6: 46,129,993-46,146,699 |
ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) |
59084 | Q9UJA9 | chr6: 46,159,187-46,170,971 |
ENTPD3 | ectonucleoside triphosphate diphosphohydrolase 3 |
956 | O75355 | chr3: 40,387,156-40,428,619 |
ENTPD6 | ectonucleoside triphosphate diphosphohydrolase 6 (putative) |
955 | O75354 | chr20: 25,195,693-25,226,729 |
EPB41L1 | erythrocyte membrane protein band 4.1-like 1 |
2036 | Q9H4G0 | chr20: 36,091,504-36,232,799 |
EPB41L3 | erythrocyte membrane protein band 4.1-like 3 |
23136 | Q9Y2J2 | chr18: 5,392,381-5,630,700 |
EPCAM | epithelial cell adhesion molecule |
4072 | P16422 | chr2: 47,345,158-47,387,601 |
EPHA3 | EPH receptor A3 |
2042 | P29320 | chr3: 89,107,524-89,482,134 |
EPHA4 | EPH receptor A4 |
2043 | P54764 | chr2: 221,418,027-221,574,202 |
EPHA5 | EPH receptor A5 |
2044 | P54756 | chr4: 65,319,563-65,670,495 |
EPHA6 | EPH receptor A6 |
285220 | Q9UF33 | chr3: 96,814,581-97,752,460 |
EPHB1 | EPH receptor B1 |
2047 | P54762 | chr3: 134,597,801-135,260,467 |
EPHB2 | EPH receptor B2 |
2048 | P29323 | chr1: 22,710,839-22,921,500 |
EPHB4 | EPH receptor B4 |
2050 | P54760 | chr7: 100,802,565-100,827,521 |
EPS15 | epidermal growth factor receptor pathway substrate 15 |
2060 | P42566 | chr1: 51,354,263-51,519,328 |
ERAP1 | endoplasmic reticulum aminopeptidase 1 |
51752 | Q9NZ08 | chr5: 96,760,810-96,808,100 |
ERAP2 | endoplasmic reticulum aminopeptidase 2 |
64167 | Q6P179 | chr5: 96,875,939-96,919,716 |
ERBB2 | erb-b2 receptor tyrosine kinase 2 |
2064 | P04626 | chr17: 39,687,914-39,730,426 |
ERBB3 | erb-b2 receptor tyrosine kinase 3 |
2065 | P21860 | chr12: 56,079,857-56,103,505 |
ERBB4 | erb-b2 receptor tyrosine kinase 4 |
2066 | Q15303 | chr2: 211,375,717-212,538,841 |
ERCC6L | excision repair cross-complementation group 6 like |
54821 | Q2NKX8 | chrX: 72,204,657-72,239,047 |
ERLIN2 | ER lipid raft associated 2 |
11160 | O94905 | chr8: 37,736,599-37,759,101 |
ERMAP | erythroblast membrane-associated protein (Scianna blood group) |
114625 | Q96PL5 | chr1: 42,817,124-42,844,989 |
ERVW-1 | endogenous retrovirus group W member 1 |
30816 | Q9UQF0 | chr7: 92,468,380-92,477,986 |
ESR1 | estrogen receptor 1 |
2099 | P03372 | chr6: 151,656,691-152,129,619 |
ESYT1 | extended synaptotagmin-like protein 1 |
23344 | Q9BSJ8 | chr12: 56,118,250-56,144,671 |
ETNK1 | ethanolamine kinase 1 |
55500 | Q9HBU6 | chr12: 22,625,075-22,690,665 |
ETS2 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
2114 | P15036 | chr21: 38,805,307-38,824,955 |
ETV5 | ets variant 5 |
2119 | P41161 | chr3: 186,046,308-186,110,318 |
EWSR1 | EWS RNA binding protein 1 |
2130 | Q01844 | chr22: 29,268,009-29,300,525 |
EXOC1 | exocyst complex component 1 |
55763 | Q9NV70 | chr4: 55,853,616-55,905,034 |
EXOC2 | exocyst complex component 2 |
55770 | Q96KP1 | chr6: 485,133-693,111 |
EXOC4 | exocyst complex component 4 |
60412 | Q96A65 | chr7: 133,253,073-134,066,589 |
EXOC7 | exocyst complex component 7 |
23265 | Q9UPT5 | chr17: 76,081,017-76,121,576 |
EZR | ezrin |
7430 | P15311 | chr6: 158,765,741-158,819,412 |
F11R | F11 receptor |
50848 | Q9Y624 | chr1: 160,995,211-161,021,348 |
F2 | coagulation factor II (thrombin) |
2147 | P00734 | chr11: 46,719,180-46,739,506 |
F2R | coagulation factor II (thrombin) receptor |
2149 | P25116 | chr5: 76,716,043-76,735,781 |
F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
2150 | P55085 | chr5: 76,818,933-76,835,315 |
F5 | coagulation factor V (proaccelerin, labile factor) |
2153 | P12259 | chr1: 169,514,166-169,586,588 |
F8 | coagulation factor VIII, procoagulant component |
2157 | P00451 | chrX: 154,835,788-155,026,940 |
FADD | Fas associated via death domain |
8772 | Q13158 | chr11: 70,203,163-70,207,390 |
FAM120A | family with sequence similarity 120A |
23196 | Q9NZB2 | chr9: 93,451,722-93,566,107 |
FAM126B | family with sequence similarity 126 member B |
285172 | Q8IXS8 | chr2: 200,973,718-201,071,671 |
FAM129A | family with sequence similarity 129 member A |
116496 | Q9BZQ8 | chr1: 184,790,724-184,974,550 |
FAM129B | family with sequence similarity 129 member B |
64855 | Q96TA1 | chr9: 127,505,339-127,578,989 |
FAM84B | family with sequence similarity 84 member B |
157638 | Q96KN1 | chr8: 126,552,442-126,558,393 |
FANCG | Fanconi anemia complementation group G |
2189 | O15287 | chr9: 35,073,835-35,080,016 |
FAS | Fas cell surface death receptor |
355 | P25445 | chr10: 88,990,582-89,015,785 |
FASN | fatty acid synthase |
2194 | P49327 | chr17: 82,078,333-82,098,332 |
FAT1 | FAT atypical cadherin 1 |
2195 | Q14517 | chr4: 186,587,783-186,726,722 |
FAT3 | FAT atypical cadherin 3 |
120114 | Q8TDW7 | chr11: 92,352,096-92,896,470 |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
2209 | P12314 | chr1: 149,782,671-149,792,518 |
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) |
2210 | Q92637 | chr1: 121,087,345-121,096,310 |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) |
2212 | P12318 | chr1: 161,505,430-161,524,013 |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
2213 | P31994 | chr1: 161,663,147-161,678,654 |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
2215 | O75015 | chr1: 161,623,196-161,631,963 |
FCHO2 | FCH domain only 2 |
115548 | Q0JRZ9 | chr5: 72,955,981-73,090,522 |
FCRL1 | Fc receptor-like 1 |
115350 | Q96LA6 | chr1: 157,794,403-157,820,105 |
FEN1 | flap structure-specific endonuclease 1 |
2237 | P39748 | chr11: 61,792,637-61,797,244 |
FEZ1 | fasciculation and elongation protein zeta 1 |
9638 | Q99689 | chr11: 125,445,745-125,496,317 |
FGA | fibrinogen alpha chain |
2243 | P02671 | chr4: 154,583,126-154,590,766 |
FGB | fibrinogen beta chain |
2244 | P02675 | chr4: 154,562,956-154,571,086 |
FGF13 | fibroblast growth factor 13 |
2258 | Q92913 | chrX: 138,614,731-139,222,777 |
FGFR1 | fibroblast growth factor receptor 1 |
2260 | P11362 | chr8: 38,411,138-38,468,834 |
FGFR2 | fibroblast growth factor receptor 2 |
2263 | P21802 | chr10: 121,478,334-121,598,458 |
FGG | fibrinogen gamma chain |
2266 | P02679 | chr4: 154,604,134-154,612,967 |
FGR | FGR proto-oncogene, Src family tyrosine kinase |
2268 | P09769 | chr1: 27,612,064-27,635,277 |
FHL1 | four and a half LIM domains 1 |
2273 | Q13642 | chrX: 136,146,702-136,211,359 |
FLCN | folliculin |
201163 | Q8NFG4 | chr17: 17,212,212-17,237,188 |
FLNA | filamin A |
2316 | P21333 | chrX: 154,348,524-154,374,638 |
FLNB | filamin B |
2317 | O75369 | chr3: 58,008,400-58,172,251 |
FLNC | filamin C |
2318 | Q14315 | chr7: 128,830,377-128,859,274 |
FLOT1 | flotillin 1 |
10211 | O75955 | chr6: 30,727,709-30,742,733 |
FLRT1 | fibronectin leucine rich transmembrane protein 1 |
23769 | Q9NZU1 | chr11: 64,103,188-64,119,173 |
FLRT2 | fibronectin leucine rich transmembrane protein 2 |
23768 | O43155 | chr14: 85,530,144-85,654,426 |
FLRT3 | fibronectin leucine rich transmembrane protein 3 |
23767 | Q9NZU0 | chr20: 14,322,988-14,337,616 |
FLT4 | fms-related tyrosine kinase 4 |
2324 | P35916 | chr5: 180,601,506-180,649,624 |
FLVCR2 | feline leukemia virus subgroup C cellular receptor family member 2 |
55640 | Q9UPI3 | chr14: 75,578,617-75,663,214 |
FMN2 | formin 2 |
56776 | Q9NZ56 | chr1: 240,014,348-240,475,189 |
FNBP1 | formin binding protein 1 |
23048 | Q96RU3 | chr9: 129,887,187-130,043,194 |
FNBP1L | formin binding protein 1-like |
54874 | Q5T0N5 | chr1: 93,448,131-93,554,661 |
FNDC4 | fibronectin type III domain containing 4 |
64838 | Q9H6D8 | chr2: 27,491,883-27,495,245 |
FNIP2 | folliculin interacting protein 2 |
57600 | Q9P278 | chr4: 158,769,138-158,908,049 |
FOLR1 | folate receptor 1 (adult) |
2348 | P15328 | chr11: 72,189,558-72,196,323 |
FPR1 | formyl peptide receptor 1 |
2357 | P21462 | chr19: 51,745,172-51,804,110 |
FPR2 | formyl peptide receptor 2 |
2358 | P25090 | chr19: 51,752,026-51,770,526 |
FRAS1 | Fraser extracellular matrix complex subunit 1 |
80144 | Q86XX4 | chr4: 78,057,570-78,544,269 |
FRMD6 | FERM domain containing 6 |
122786 | Q96NE9 | chr14: 51,489,100-51,730,727 |
FRS2 | fibroblast growth factor receptor substrate 2 |
10818 | Q8WU20 | chr12: 69,470,349-69,579,789 |
FSHR | follicle stimulating hormone receptor |
2492 | P23945 | chr2: 48,962,157-49,154,537 |
FURIN | furin (paired basic amino acid cleaving enzyme) |
5045 | P09958 | chr15: 90,868,592-90,883,458 |
FXYD1 | FXYD domain containing ion transport regulator 1 |
5348 | O00168 | chr19: 35,138,808-35,143,109 |
FXYD4 | FXYD domain containing ion transport regulator 4 |
53828 | P59646 | chr10: 43,371,642-43,376,335 |
FYB | FYN binding protein |
2533 | O15117 | chr5: 39,105,236-39,274,528 |
FYN | FYN proto-oncogene, Src family tyrosine kinase |
2534 | P06241 | chr6: 111,660,332-111,873,452 |
FZD4 | frizzled class receptor 4 |
8322 | Q9ULV1 | chr11: 86,945,679-86,955,391 |
FZD6 | frizzled class receptor 6 |
8323 | O60353 | chr8: 103,298,433-103,332,866 |
FZD7 | frizzled class receptor 7 |
8324 | O75084 | chr2: 202,034,587-202,038,445 |
G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 |
10146 | Q13283 | chr5: 151,771,045-151,812,785 |
GABBR1 | gamma-aminobutyric acid (GABA) B receptor, 1 |
2550 | Q9UBS5 | chr6: 29,555,629-29,633,976 |
GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 |
9568 | O75899 | chr9: 98,288,082-98,709,197 |
GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
2558 | P31644 | chr15: 26,866,363-26,949,207 |
GAP43 | growth associated protein 43 |
2596 | P17677 | chr3: 115,623,324-115,721,490 |
GAPDH | glyceraldehyde-3-phosphate dehydrogenase |
2597 | P04406 | chr12: 6,533,927-6,538,374 |
GAREM1 | GRB2 associated regulator of MAPK1 subtype 1 |
64762 | Q9H706 | chr18: 32,124,877-32,470,484 |
GAS1 | growth arrest specific 1 |
2619 | P54826 | chr9: 86,944,363-86,947,189 |
GBA2 | glucosidase, beta (bile acid) 2 |
57704 | Q9HCG7 | chr9: 35,736,866-35,749,228 |
GBP1 | guanylate binding protein 1, interferon-inducible |
2633 | P32455 | chr1: 89,052,319-89,065,360 |
GCG | glucagon |
2641 | P01275 | chr2: 162,142,873-162,152,404 |
GDE1 | glycerophosphodiester phosphodiesterase 1 |
51573 | Q9NZC3 | chr16: 19,501,689-19,522,145 |
GDF5 | growth differentiation factor 5 |
8200 | P43026 | chr20: 35,433,347-35,454,746 |
GHR | growth hormone receptor |
2690 | P10912 | chr5: 42,423,777-42,721,878 |
GHSR | growth hormone secretagogue receptor |
2693 | Q92847 | chr3: 172,445,133-172,448,456 |
GJA1 | gap junction protein alpha 1 |
2697 | P17302 | chr6: 121,435,692-121,449,727 |
GJC1 | gap junction protein gamma 1 |
10052 | P36383 | chr17: 44,798,448-44,830,816 |
GLDN | gliomedin |
342035 | Q6ZMI3 | chr15: 51,341,629-51,408,013 |
GLG1 | golgi glycoprotein 1 |
2734 | Q92896 | chr16: 74,447,427-74,607,144 |
GLIPR1 | GLI pathogenesis-related 1 |
11010 | P48060 | chr12: 75,480,680-75,503,853 |
GLRB | glycine receptor beta |
2743 | P48167 | chr4: 157,076,057-157,172,090 |
GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
2767 | P29992 | chr19: 3,094,410-3,124,004 |
GNA12 | guanine nucleotide binding protein (G protein) alpha 12 |
2768 | Q03113 | chr7: 2,728,112-2,844,324 |
GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
2770 | P63096 | chr7: 80,133,955-80,219,402 |
GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
2771 | P04899 | chr3: 50,226,292-50,259,355 |
GNAI3 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
2773 | P08754 | chr1: 109,548,611-109,618,321 |
GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
2776 | P50148 | chr9: 77,716,087-78,031,458 |
GNAS | GNAS complex locus |
2778 | P84996 | chr20: 58,839,718-58,911,192 |
GNAS | GNAS complex locus |
2778 | Q5JWF2 | chr20: 58,839,718-58,911,192 |
GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
2782 | P62873 | chr1: 1,785,285-1,891,117 |
GNB2 | guanine nucleotide binding protein (G protein), beta polypeptide 2 |
2783 | P62879 | chr7: 100,673,531-100,679,174 |
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 |
2784 | P16520 | chr12: 6,839,954-6,847,393 |
GNG11 | guanine nucleotide binding protein (G protein), gamma 11 |
2791 | P61952 | chr7: 93,921,699-93,928,610 |
GNG4 | guanine nucleotide binding protein (G protein), gamma 4 |
2786 | P50150 | chr1: 235,547,687-235,650,754 |
GNG5 | guanine nucleotide binding protein (G protein), gamma 5 |
2787 | P63218 | chr1: 84,498,325-84,506,565 |
GNG7 | guanine nucleotide binding protein (G protein), gamma 7 |
2788 | O60262 | chr19: 2,511,219-2,702,709 |
GNRHR | gonadotropin releasing hormone receptor |
2798 | P30968 | chr4: 67,739,328-67,754,360 |
GOPC | golgi-associated PDZ and coiled-coil motif containing |
57120 | Q9HD26 | chr6: 117,560,269-117,602,542 |
GOT2 | glutamic-oxaloacetic transaminase 2 |
2806 | P00505 | chr16: 58,707,131-58,734,357 |
GP1BB | glycoprotein Ib (platelet), beta polypeptide |
2812 | P13224 | chr22: 19,722,945-19,724,771 |
GPAM | glycerol-3-phosphate acyltransferase, mitochondrial |
57678 | Q9HCL2 | chr10: 112,149,864-112,215,377 |
GPC1 | glypican 1 |
2817 | P35052 | chr2: 240,435,671-240,468,078 |
GPC2 | glypican 2 |
221914 | Q8N158 | chr7: 100,169,606-100,177,372 |
GPC4 | glypican 4 |
2239 | O75487 | chrX: 133,300,103-133,415,490 |
GPC6 | glypican 6 |
10082 | Q9Y625 | chr13: 93,226,842-94,407,401 |
GPER1 | G protein-coupled estrogen receptor 1 |
2852 | Q99527 | chr7: 1,082,208-1,093,815 |
GPHN | gephyrin |
10243 | Q9NQX3 | chr14: 66,507,407-67,181,803 |
GPI | glucose-6-phosphate isomerase |
2821 | P06744 | chr19: 34,359,480-34,402,156 |
GPM6B | glycoprotein M6B |
2824 | Q13491 | chrX: 13,771,031-13,938,638 |
GPNMB | glycoprotein (transmembrane) nmb |
10457 | Q14956 | chr7: 23,235,967-23,275,108 |
GPR126 | adhesion G protein-coupled receptor G6 |
57211 | Q86SQ4 | chr6: 142,301,854-142,446,266 |
GPR146 | G protein-coupled receptor 146 |
115330 | Q96CH1 | chr7: 1,044,576-1,059,261 |
GPR157 | G protein-coupled receptor 157 |
80045 | Q5UAW9 | chr1: 9,100,305-9,129,170 |
GPR158 | G protein-coupled receptor 158 |
57512 | Q5T848 | chr10: 25,175,062-25,602,226 |
GPR160 | G protein-coupled receptor 160 |
26996 | Q9UJ42 | chr3: 170,037,929-170,085,403 |
GPR176 | G protein-coupled receptor 176 |
11245 | Q14439 | chr15: 39,799,032-39,920,892 |
GPR183 | G protein-coupled receptor 183 |
1880 | P32249 | chr13: 99,294,530-99,307,405 |
GPR27 | G protein-coupled receptor 27 |
2850 | Q9NS67 | chr3: 71,754,050-71,756,496 |
GPR32 | G protein-coupled receptor 32 |
2854 | O75388 | chr19: 50,770,464-50,771,732 |
GPR37 | G protein-coupled receptor 37 (endothelin receptor type B-like) |
2861 | O15354 | chr7: 124,745,997-124,765,627 |
GPR63 | G protein-coupled receptor 63 |
81491 | Q9BZJ6 | chr6: 96,794,126-96,837,463 |
GPR98 | adhesion G protein-coupled receptor V1 |
84059 | Q8WXG9 | chr5: 90,529,344-91,164,437 |
GPRC5A | G protein-coupled receptor, class C, group 5, member A |
9052 | Q8NFJ5 | chr12: 12,890,782-12,917,937 |
GPRC5B | G protein-coupled receptor, class C, group 5, member B |
51704 | Q9NZH0 | chr16: 19,856,691-19,886,167 |
GPSM1 | G-protein signaling modulator 1 |
26086 | Q86YR5 | chr9: 136,327,476-136,359,605 |
GPSM3 | G-protein signaling modulator 3 |
63940 | Q9Y4H4 | chr6: 32,190,766-32,195,523 |
GRB10 | growth factor receptor bound protein 10 |
2887 | Q13322 | chr7: 50,590,063-50,793,462 |
GRB14 | growth factor receptor bound protein 14 |
2888 | Q14449 | chr2: 164,492,812-164,621,848 |
GRB2 | growth factor receptor bound protein 2 |
2885 | P62993 | chr17: 75,318,076-75,405,709 |
GRIA4 | glutamate receptor, ionotropic, AMPA 4 |
2893 | P48058 | chr11: 105,609,994-105,982,092 |
GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
2903 | Q12879 | chr16: 9,753,404-10,182,754 |
GRK5 | G protein-coupled receptor kinase 5 |
2869 | P34947 | chr10: 119,207,589-119,459,742 |
GRK6 | G protein-coupled receptor kinase 6 |
2870 | P43250 | chr5: 177,403,204-177,442,901 |
GRM3 | glutamate receptor, metabotropic 3 |
2913 | Q14832 | chr7: 86,643,914-86,864,884 |
GRM6 | glutamate receptor, metabotropic 6 |
2916 | O15303 | chr5: 178,978,327-178,996,206 |
GRM8 | glutamate receptor, metabotropic 8 |
2918 | O00222 | chr7: 126,438,598-127,253,294 |
GSDMA | gasdermin A |
284110 | Q96QA5 | chr17: 39,953,263-39,977,766 |
GSDMB | gasdermin B |
55876 | Q8TAX9 | chr17: 39,904,595-39,919,854 |
GSK3B | glycogen synthase kinase 3 beta |
2932 | P49841 | chr3: 119,821,323-120,094,417 |
GSTP1 | glutathione S-transferase pi 1 |
2950 | P09211 | chr11: 67,583,595-67,586,660 |
GYPA | glycophorin A (MNS blood group) |
2993 | P02724 | chr4: 144,109,303-144,870,953 |
GYPC | glycophorin C (Gerbich blood group) |
2995 | P04921 | chr2: 126,655,933-126,696,675 |
HAUS7 | HAUS augmin like complex subunit 7 |
55559 | Q99871 | chrX: 153,447,666-153,495,516 |
HBEGF | heparin-binding EGF-like growth factor |
1839 | Q99075 | chr5: 140,332,843-140,346,631 |
HCFC2 | host cell factor C2 |
29915 | Q9Y5Z7 | chr12: 104,064,457-104,106,524 |
HDAC3 | histone deacetylase 3 |
8841 | O15379 | chr5: 141,620,876-141,636,870 |
HDAC8 | histone deacetylase 8 |
55869 | Q9BY41 | chrX: 72,329,516-72,573,103 |
HDLBP | high density lipoprotein binding protein |
3069 | Q00341 | chr2: 241,227,264-241,317,061 |
HEPH | hephaestin |
9843 | Q9BQS7 | chrX: 66,162,549-66,268,867 |
HFE | hemochromatosis |
3077 | Q30201 | chr6: 26,087,281-26,098,343 |
HINT1 | histidine triad nucleotide binding protein 1 |
3094 | P49773 | chr5: 131,159,027-131,171,735 |
HLA-A | major histocompatibility complex, class I, A |
3105 | P30443 | chr6: 29,941,260-29,945,884 |
HLA-B | major histocompatibility complex, class I, B |
3106 | P01889 | chr6: 31,269,491-31,357,188 |
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 |
3113 | P20036 | chr6: 33,064,569-33,080,775 |
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
3117 | P01909 | chr6: 32,628,179-32,647,062 |
HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 |
3118 | P01906 | chr6: 32,741,342-32,747,215 |
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
3119 | P01920 | chr6: 32,659,467-32,668,383 |
HLA-DRA | major histocompatibility complex, class II, DR alpha |
3122 | P01903 | chr6: 32,439,842-32,445,046 |
HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 |
3125 | P79483 | chr6: 32,444,128-32,457,245 |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 |
3126 | P13762 | chr6: 32,542,598-32,557,561 |
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
3127 | Q30154 | chr6: 32,517,343-32,530,287 |
HLA-E | major histocompatibility complex, class I, E |
3133 | P13747 | chr6: 30,489,467-30,494,205 |
HLA-F | major histocompatibility complex, class I, F |
3134 | P30511 | chr6: 29,722,775-29,738,528 |
HLA-G | major histocompatibility complex, class I, G |
3135 | P17693 | chr6: 29,826,967-29,831,125 |
HM13 | histocompatibility (minor) 13 |
81502 | Q8TCT9 | chr20: 31,514,428-31,577,923 |
HMGB1 | high mobility group box 1 |
3146 | P09429 | chr13: 30,456,704-30,617,597 |
HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 |
3157 | Q01581 | chr5: 43,289,395-43,313,512 |
HMMR | hyaluronan-mediated motility receptor (RHAMM) |
3161 | O75330 | chr5: 163,460,203-163,491,945 |
HN1L | hematological and neurological expressed 1-like |
90861 | Q9H910 | chr16: 1,678,256-1,702,280 |
HOMER3 | homer scaffolding protein 3 |
9454 | Q9NSC5 | chr19: 18,929,201-18,941,261 |
HRH1 | histamine receptor H1 |
3269 | P35367 | chr3: 11,137,093-11,263,557 |
HRH3 | histamine receptor H3 |
11255 | Q9Y5N1 | chr20: 62,214,970-62,220,267 |
HSD17B10 | hydroxysteroid (17-beta) dehydrogenase 10 |
3028 | Q99714 | chrX: 53,431,258-53,434,373 |
HSD17B7 | hydroxysteroid (17-beta) dehydrogenase 7 |
51478 | P56937 | chr1: 162,790,702-162,812,817 |
HSP90AA1 | heat shock protein 90kDa alpha family class A member 1 |
3320 | P07900 | chr14: 102,080,738-102,139,699 |
HSP90B1 | heat shock protein 90kDa beta family member 1 |
7184 | P14625 | chr12: 103,930,107-103,953,645 |
HSPA5 | heat shock protein family A (Hsp70) member 5 |
3309 | P11021 | chr9: 125,234,853-125,241,330 |
HSPB1 | heat shock protein family B (small) member 1 |
3315 | P04792 | chr7: 76,302,544-76,304,295 |
HSPD1 | heat shock protein family D (Hsp60) member 1 |
3329 | P10809 | chr2: 197,486,581-197,516,737 |
HSPG2 | heparan sulfate proteoglycan 2 |
3339 | P98160 | chr1: 21,822,245-21,937,297 |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
3357 | P41595 | chr2: 231,108,230-231,125,118 |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
3358 | P28335 | chrX: 114,584,078-114,910,061 |
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
3363 | P34969 | chr10: 90,740,823-90,857,698 |
HTRA1 | HtrA serine peptidase 1 |
5654 | Q92743 | chr10: 122,461,525-122,514,908 |
HYAL2 | hyaluronoglucosaminidase 2 |
8692 | Q12891 | chr3: 50,317,790-50,322,906 |
ICAM1 | intercellular adhesion molecule 1 |
3383 | P05362 | chr19: 10,270,835-10,286,615 |
IDE | insulin-degrading enzyme |
3416 | P14735 | chr10: 92,451,684-92,574,076 |
IFIT5 | interferon induced protein with tetratricopeptide repeats 5 |
24138 | Q13325 | chr10: 89,414,586-89,421,001 |
IFITM1 | interferon induced transmembrane protein 1 |
8519 | P13164 | chr11: 313,506-315,272 |
IFITM3 | interferon induced transmembrane protein 3 |
10410 | Q01628 | chr11: 319,669-327,537 |
IFNAR1 | interferon (alpha, beta and omega) receptor 1 |
3454 | P17181 | chr21: 33,324,477-33,359,862 |
IFNAR2 | interferon (alpha, beta and omega) receptor 2 |
3455 | P48551 | chr21: 33,229,901-33,265,675 |
IFNGR1 | interferon gamma receptor 1 |
3459 | P15260 | chr6: 137,197,484-137,219,449 |
IFNGR2 | interferon gamma receptor 2 (interferon gamma transducer 1) |
3460 | P38484 | chr21: 33,402,896-33,479,348 |
IFT122 | intraflagellar transport 122 |
55764 | Q9HBG6 | chr3: 129,440,036-129,520,507 |
IGDCC4 | immunoglobulin superfamily, DCC subclass, member 4 |
57722 | Q8TDY8 | chr15: 65,381,464-65,423,072 |
IGF1 | insulin like growth factor 1 |
3479 | P05019 | chr12: 102,395,867-102,480,645 |
IGF1R | insulin like growth factor 1 receptor |
3480 | P08069 | chr15: 98,648,971-98,964,530 |
IGF2 | insulin like growth factor 2 |
3481 | P01344 | chr11: 2,129,112-2,141,238 |
IGSF11 | immunoglobulin superfamily member 11 |
152404 | Q5DX21 | chr3: 118,900,557-119,146,068 |
IL10RB | interleukin 10 receptor subunit beta |
3588 | Q08334 | chr21: 33,266,358-33,310,187 |
IL12RB1 | interleukin 12 receptor subunit beta 1 |
3594 | P42701 | chr19: 18,058,995-18,098,944 |
IL17RB | interleukin 17 receptor B |
55540 | Q9NRM6 | chr3: 53,846,580-53,865,800 |
IL18R1 | interleukin 18 receptor 1 |
8809 | Q13478 | chr2: 102,311,529-102,398,775 |
IL1R1 | interleukin 1 receptor, type I |
3554 | P14778 | chr2: 102,064,544-102,179,874 |
IL1R2 | interleukin 1 receptor, type II |
7850 | P27930 | chr2: 101,991,844-102,028,544 |
IL1RAP | interleukin 1 receptor accessory protein |
3556 | Q9NPH3 | chr3: 190,514,051-190,659,750 |
IL1RL1 | interleukin 1 receptor-like 1 |
9173 | Q01638 | chr2: 102,311,502-102,352,037 |
IL1RN | interleukin 1 receptor antagonist |
3557 | P18510 | chr2: 113,107,214-113,134,016 |
IL5RA | interleukin 5 receptor subunit alpha |
3568 | Q01344 | chr3: 3,066,326-3,126,613 |
IL6R | interleukin 6 receptor |
3570 | P08887 | chr1: 154,405,193-154,469,450 |
IL6ST | interleukin 6 signal transducer |
3572 | P40189 | chr5: 55,935,095-55,994,993 |
IL7R | interleukin 7 receptor |
3575 | P16871 | chr5: 35,852,695-35,879,603 |
ILK | integrin linked kinase |
3611 | Q13418 | chr11: 6,603,708-6,610,874 |
INADL | InaD-like (Drosophila) |
10207 | Q8NI35 | chr1: 61,742,477-62,178,675 |
INO80B | INO80 complex subunit B |
83444 | Q9C086 | chr2: 74,455,023-74,457,960 |
INPP5A | inositol polyphosphate-5-phosphatase A |
3632 | Q14642 | chr10: 132,537,820-132,783,480 |
INPP5D | inositol polyphosphate-5-phosphatase D |
3635 | Q92835 | chr2: 233,059,967-233,207,903 |
INPP5E | inositol polyphosphate-5-phosphatase E |
56623 | Q9NRR6 | chr9: 136,428,619-136,439,823 |
INPP5K | inositol polyphosphate-5-phosphatase K |
51763 | Q9BT40 | chr17: 1,494,571-1,516,888 |
INSR | insulin receptor |
3643 | P06213 | chr19: 7,112,255-7,294,034 |
IPCEF1 | interaction protein for cytohesin exchange factors 1 |
26034 | Q8WWN9 | chr6: 154,154,496-154,356,792 |
IQGAP1 | IQ motif containing GTPase activating protein 1 |
8826 | P46940 | chr15: 90,388,218-90,502,243 |
IRAK1 | interleukin 1 receptor associated kinase 1 |
3654 | P51617 | chrX: 154,010,500-154,019,980 |
IRAK2 | interleukin 1 receptor associated kinase 2 |
3656 | O43187 | chr3: 10,164,865-10,243,743 |
IRS1 | insulin receptor substrate 1 |
3667 | P35568 | chr2: 226,731,317-226,799,759 |
IRS2 | insulin receptor substrate 2 |
8660 | Q9Y4H2 | chr13: 109,752,698-109,786,568 |
IRS4 | insulin receptor substrate 4 |
8471 | O14654 | chrX: 108,732,482-108,736,409 |
ITCH | itchy E3 ubiquitin protein ligase |
83737 | Q96J02 | chr20: 34,363,235-34,511,393 |
ITGA10 | integrin subunit alpha 10 |
8515 | O75578 | chr1: 145,891,208-145,910,189 |
ITGA11 | integrin subunit alpha 11 |
22801 | Q9UKX5 | chr15: 68,296,533-68,432,162 |
ITGA2 | integrin subunit alpha 2 |
3673 | P17301 | chr5: 52,989,326-53,094,779 |
ITGA3 | integrin subunit alpha 3 |
3675 | P26006 | chr17: 50,055,968-50,090,481 |
ITGA5 | integrin subunit alpha 5 |
3678 | P08648 | chr12: 54,395,261-54,419,460 |
ITGA6 | integrin subunit alpha 6 |
3655 | P23229 | chr2: 172,427,354-172,506,282 |
ITGA9 | integrin subunit alpha 9 |
3680 | Q13797 | chr3: 37,452,115-37,823,514 |
ITGAE | integrin subunit alpha E |
3682 | P38570 | chr17: 3,714,628-3,801,243 |
ITGAM | integrin subunit alpha M |
3684 | P11215 | chr16: 31,259,990-31,332,892 |
ITGAV | integrin subunit alpha V |
3685 | P06756 | chr2: 186,590,065-186,680,901 |
ITGAX | integrin subunit alpha X |
3687 | P20702 | chr16: 31,355,134-31,382,997 |
ITGB1 | integrin subunit beta 1 |
3688 | P05556 | chr10: 32,900,319-33,005,792 |
ITGB1BP1 | integrin subunit beta 1 binding protein 1 |
9270 | O14713 | chr2: 9,403,475-9,423,547 |
ITGB2 | integrin subunit beta 2 |
3689 | P05107 | chr21: 44,885,953-44,931,989 |
ITGB3 | integrin subunit beta 3 |
3690 | P05106 | chr17: 47,253,846-47,311,816 |
ITGB4 | integrin subunit beta 4 |
3691 | P16144 | chr17: 75,721,328-75,757,818 |
ITGB5 | integrin subunit beta 5 |
3693 | P18084 | chr3: 124,761,948-124,901,418 |
ITGB8 | integrin subunit beta 8 |
3696 | P26012 | chr7: 20,330,702-20,415,754 |
ITM2A | integral membrane protein 2A |
9452 | O43736 | chrX: 79,360,384-79,367,667 |
ITM2B | integral membrane protein 2B |
9445 | Q9Y287 | chr13: 48,233,158-48,270,357 |
ITPR1 | inositol 1,4,5-trisphosphate receptor, type 1 |
3708 | Q14643 | chr3: 4,493,348-4,847,840 |
ITPR2 | inositol 1,4,5-trisphosphate receptor, type 2 |
3709 | Q14571 | chr12: 26,336,515-26,833,198 |
ITPR3 | inositol 1,4,5-trisphosphate receptor, type 3 |
3710 | Q14573 | chr6: 33,620,365-33,696,574 |
ITPRIP | inositol 1,4,5-trisphosphate receptor interacting protein |
85450 | Q8IWB1 | chr10: 104,309,698-104,338,404 |
ITSN1 | intersectin 1 |
6453 | Q15811 | chr21: 33,642,400-33,899,861 |
JADE1 | jade family PHD finger 1 |
79960 | Q6IE81 | chr4: 128,809,623-128,875,224 |
JAG1 | jagged 1 |
182 | P78504 | chr20: 10,637,684-10,674,107 |
JAM2 | junctional adhesion molecule 2 |
58494 | P57087 | chr21: 25,639,272-25,717,562 |
JAM3 | junctional adhesion molecule 3 |
83700 | Q9BX67 | chr11: 134,068,925-134,152,001 |
JMJD6 | jumonji domain containing 6 |
23210 | Q6NYC1 | chr17: 76,712,832-76,726,799 |
JOSD1 | Josephin domain containing 1 |
9929 | Q15040 | chr22: 38,685,543-38,701,556 |
JUP | junction plakoglobin |
3728 | P14923 | chr17: 41,754,604-41,786,931 |
KANK1 | KN motif and ankyrin repeat domains 1 |
23189 | Q14678 | chr9: 470,291-746,106 |
KARS | lysyl-tRNA synthetase |
3735 | Q15046 | chr16: 75,627,474-75,648,643 |
KATNB1 | katanin p80 (WD repeat containing) subunit B 1 |
10300 | Q9BVA0 | chr16: 57,735,730-57,757,250 |
KCNA1 | potassium channel, voltage gated shaker related subfamily A, member 1 |
3736 | Q09470 | chr12: 4,909,893-4,918,256 |
KCNC3 | potassium channel, voltage gated Shaw related subfamily C, member 3 |
3748 | Q14003 | chr19: 50,311,937-50,333,515 |
KCNG1 | potassium channel, voltage gated modifier subfamily G, member 1 |
3755 | Q9UIX4 | chr20: 51,003,656-51,023,129 |
KCNG3 | potassium channel, voltage gated modifier subfamily G, member 3 |
170850 | Q8TAE7 | chr2: 42,442,017-42,494,097 |
KCNH2 | potassium channel, voltage gated eag related subfamily H, member 2 |
3757 | Q12809 | chr7: 150,944,961-150,978,315 |
KCNIP2 | Kv channel interacting protein 2 |
30819 | Q9NS61 | chr10: 101,825,974-101,843,920 |
KCNJ11 | potassium channel, inwardly rectifying subfamily J, member 11 |
3767 | Q14654 | chr11: 17,385,859-17,389,331 |
KCNJ12 | potassium channel, inwardly rectifying subfamily J, member 12 |
3768 | Q14500 | chr17: 21,376,197-21,419,872 |
KCNK1 | potassium channel, two pore domain subfamily K, member 1 |
3775 | O00180 | chr1: 233,614,004-233,672,512 |
KCNK17 | potassium channel, two pore domain subfamily K, member 17 |
89822 | Q96T54 | chr6: 39,299,001-39,314,553 |
KCNK3 | potassium channel, two pore domain subfamily K, member 3 |
3777 | O14649 | chr2: 26,692,690-26,733,420 |
KCNK6 | potassium channel, two pore domain subfamily K, member 6 |
9424 | Q9Y257 | chr19: 38,319,844-38,332,076 |
KCNMA1 | potassium channel, calcium activated large conductance subfamily M alpha, member 1 |
3778 | Q12791 | chr10: 76,869,601-77,638,369 |
KCNV2 | potassium channel, voltage gated modifier subfamily V, member 2 |
169522 | Q8TDN2 | chr9: 2,717,502-2,730,037 |
KCTD7 | potassium channel tetramerization domain containing 7 |
154881 | Q96MP8 | chr7: 66,628,767-66,649,067 |
KIAA0319L | KIAA0319-like |
79932 | Q8IZA0 | chr1: 35,433,490-35,557,950 |
KIAA0922 | KIAA0922 |
23240 | A2VDJ0 | chr4: 153,466,346-153,636,711 |
KIAA1524 | KIAA1524 |
57650 | Q8TCG1 | chr3: 108,549,869-108,589,644 |
KIF14 | kinesin family member 14 |
9928 | Q15058 | chr1: 200,551,497-200,620,734 |
KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
3812 | P43630 | chr19: 54,850,443-54,867,207 |
KISS1R | KISS1 receptor |
84634 | Q969F8 | chr19: 917,287-921,015 |
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 | P10721 | chr4: 54,657,918-54,740,715 |
KITLG | KIT ligand |
4254 | P21583 | chr12: 88,492,793-88,580,851 |
KL | klotho |
9365 | Q9UEF7 | chr13: 33,016,433-33,066,145 |
KLF9 | Kruppel-like factor 9 |
687 | Q13886 | chr9: 70,384,597-70,414,624 |
KLHL7 | kelch like family member 7 |
55975 | Q8IXQ5 | chr7: 23,105,758-23,177,914 |
KLRC1 | killer cell lectin-like receptor subfamily C, member 1 |
3821 | P26715 | chr12: 10,442,264-10,454,685 |
KMT2E | lysine (K)-specific methyltransferase 2E |
55904 | Q8IZD2 | chr7: 105,014,179-105,114,361 |
KNG1 | kininogen 1 |
3827 | P01042 | chr3: 186,717,276-186,743,954 |
KNTC1 | kinetochore associated 1 |
9735 | P50748 | chr12: 122,527,246-122,626,396 |
KRAS | Kirsten rat sarcoma viral oncogene homolog |
3845 | P01116 | chr12: 25,204,789-25,250,936 |
KRIT1 | KRIT1, ankyrin repeat containing |
889 | O00522 | chr7: 92,198,969-92,246,166 |
KRT1 | keratin 1, type II |
3848 | P04264 | chr12: 52,674,736-52,680,407 |
KRT19 | keratin 19, type I |
3880 | P08727 | chr17: 41,523,617-41,528,308 |
L3MBTL1 | l(3)mbt-like 1 (Drosophila) |
26013 | Q9Y468 | chr20: 43,507,680-43,550,950 |
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 |
3903 | Q6GTX8 | chr19: 54,351,384-54,370,558 |
LAMP1 | lysosomal-associated membrane protein 1 |
3916 | P11279 | chr13: 113,297,241-113,323,672 |
LAMP2 | lysosomal-associated membrane protein 2 |
3920 | P13473 | chrX: 120,427,827-120,469,365 |
LAMP3 | lysosomal-associated membrane protein 3 |
27074 | Q9UQV4 | chr3: 183,122,213-183,163,839 |
LAMP5 | lysosomal associated membrane protein family member 5 |
24141 | Q9UJQ1 | chr20: 9,514,358-9,530,524 |
LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 |
55004 | Q6IAA8 | chr11: 72,085,895-72,103,387 |
LCP1 | lymphocyte cytosolic protein 1 (L-plastin) |
3936 | P13796 | chr13: 46,125,920-46,211,871 |
LCT | lactase |
3938 | P09848 | chr2: 135,787,840-135,837,180 |
LDLR | low density lipoprotein receptor |
3949 | P01130 | chr19: 11,089,362-11,133,816 |
LEPR | leptin receptor |
3953 | P48357 | chr1: 65,420,652-65,641,559 |
LGALS3 | lectin, galactoside-binding, soluble, 3 |
3958 | P17931 | chr14: 55,124,110-55,145,413 |
LGR4 | leucine-rich repeat containing G protein-coupled receptor 4 |
55366 | Q9BXB1 | chr11: 27,365,961-27,472,775 |
LGR5 | leucine-rich repeat containing G protein-coupled receptor 5 |
8549 | O75473 | chr12: 71,439,770-71,586,310 |
LGR6 | leucine-rich repeat containing G protein-coupled receptor 6 |
59352 | Q9HBX8 | chr1: 202,193,901-202,319,781 |
LHCGR | luteinizing hormone/choriogonadotropin receptor |
3973 | P22888 | chr2: 48,686,775-48,755,730 |
LIFR | leukemia inhibitory factor receptor alpha |
3977 | P42702 | chr5: 38,474,963-38,608,354 |
LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
10859 | Q8NHL6 | chr19: 54,617,158-54,637,528 |
LIMA1 | LIM domain and actin binding 1 |
51474 | Q9UHB6 | chr12: 50,175,788-50,283,546 |
LIMS1 | LIM and senescent cell antigen-like domains 1 |
3987 | P48059 | chr2: 108,534,355-108,687,246 |
LIN7B | lin-7 homolog B (C. elegans) |
64130 | Q9HAP6 | chr19: 49,114,324-49,118,460 |
LIN7C | lin-7 homolog C (C. elegans) |
55327 | Q9NUP9 | chr11: 27,494,576-27,506,773 |
LIPH | lipase, member H |
200879 | Q8WWY8 | chr3: 185,506,262-185,552,613 |
LITAF | lipopolysaccharide-induced TNF factor |
9516 | Q99732 | chr16: 11,547,722-11,636,381 |
LMBRD1 | LMBR1 domain containing 1 |
55788 | Q9NUN5 | chr6: 69,675,802-69,797,111 |
LNPEP | leucyl/cystinyl aminopeptidase |
4012 | Q9UIQ6 | chr5: 96,935,394-97,037,515 |
LOC440434 | aminopeptidase puromycin sensitive pseudogene |
440434 | N/A | chr17 |
LPL | lipoprotein lipase |
4023 | P06858 | chr8: 19,901,717-19,967,258 |
LPP | LIM domain containing preferred translocation partner in lipoma |
4026 | Q93052 | chr3: 188,153,284-188,890,671 |
LPXN | leupaxin |
9404 | O60711 | chr11: 58,526,871-58,578,220 |
LRBA | LPS-responsive vesicle trafficking, beach and anchor containing |
987 | P50851 | chr4: 150,264,531-151,015,727 |
LRIG2 | leucine-rich repeats and immunoglobulin-like domains 2 |
9860 | O94898 | chr1: 113,073,209-113,132,260 |
LRIG3 | leucine-rich repeats and immunoglobulin-like domains 3 |
121227 | Q6UXM1 | chr12: 58,872,149-58,920,522 |
LRP2 | LDL receptor related protein 2 |
4036 | P98164 | chr2: 169,127,109-169,362,685 |
LRP5 | LDL receptor related protein 5 |
4041 | O75197 | chr11: 68,312,609-68,449,275 |
LRP6 | LDL receptor related protein 6 |
4040 | O75581 | chr12: 12,116,025-12,267,012 |
LRPAP1 | LDL receptor related protein associated protein 1 |
4043 | P30533 | chr4: 3,506,376-3,532,559 |
LRRC16A | leucine rich repeat containing 16A |
55604 | Q5VZK9 | chr6: 25,279,078-25,620,530 |
LRRC16B | leucine rich repeat containing 16B |
90668 | Q8ND23 | chr14: 24,052,000-24,069,728 |
LRRC8A | leucine-rich repeat containing 8 family member A |
56262 | Q8IWT6 | chr9: 128,882,112-128,918,039 |
LRRC8B | leucine-rich repeat containing 8 family member B |
23507 | Q6P9F7 | chr1: 89,524,836-89,597,864 |
LRRC8C | leucine-rich repeat containing 8 family member C |
84230 | Q8TDW0 | chr1: 89,633,072-89,769,903 |
LRRFIP1 | leucine rich repeat (in FLII) interacting protein 1 |
9208 | Q32MZ4 | chr2: 237,627,576-237,813,682 |
LSAMP | limbic system-associated membrane protein |
4045 | Q13449 | chr3: 115,802,363-117,139,389 |
LSP1 | lymphocyte-specific protein 1 |
4046 | P33241 | chr11: 1,852,970-1,892,267 |
LSR | lipolysis stimulated lipoprotein receptor |
51599 | Q86X29 | chr19: 35,248,330-35,267,964 |
LTBR | lymphotoxin beta receptor |
4055 | P36941 | chr12: 6,375,045-6,391,571 |
LTK | leukocyte receptor tyrosine kinase |
4058 | P29376 | chr15: 41,503,638-41,513,887 |
LYN | LYN proto-oncogene, Src family tyrosine kinase |
4067 | P07948 | chr8: 55,879,813-56,014,168 |
LYPD1 | LY6/PLAUR domain containing 1 |
116372 | Q8N2G4 | chr2: 132,644,853-132,671,579 |
LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 |
10894 | Q9Y5Y7 | chr11: 10,556,966-10,611,689 |
MACF1 | microtubule-actin crosslinking factor 1 |
23499 | Q9UPN3 | chr1: 39,081,316-39,487,177 |
MAG | myelin associated glycoprotein |
4099 | P20916 | chr19: 35,292,125-35,313,804 |
MAGEE1 | MAGE family member E1 |
57692 | Q9HCI5 | chrX: 76,427,724-76,431,353 |
MAGI1 | membrane associated guanylate kinase, WW and PDZ domain containing 1 |
9223 | Q96QZ7 | chr3: 65,353,525-66,038,834 |
MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 |
9863 | Q86UL8 | chr7: 78,017,057-79,453,574 |
MALL | mal, T-cell differentiation protein-like |
7851 | Q13021 | chr2: 110,083,870-110,116,566 |
MAP1B | microtubule associated protein 1B |
4131 | P46821 | chr5: 72,107,234-72,209,570 |
MAP2K1 | mitogen-activated protein kinase kinase 1 |
5604 | Q02750 | chr15: 66,386,817-66,492,312 |
MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
6885 | O43318 | chr6: 90,513,573-90,587,045 |
MAPKAP1 | mitogen-activated protein kinase associated protein 1 |
79109 | Q9BPZ7 | chr9: 125,437,393-125,707,234 |
MAPT | microtubule associated protein tau |
4137 | P10636 | chr17: 45,894,382-46,028,334 |
MARCH1 | membrane associated ring-CH-type finger 1 |
55016 | Q8TCQ1 | chr4: 163,524,298-164,384,050 |
MARCKS | myristoylated alanine-rich protein kinase C substrate |
4082 | P29966 | chr6: 113,857,362-113,863,471 |
MARK1 | MAP/microtubule affinity-regulating kinase 1 |
4139 | Q9P0L2 | chr1: 220,528,183-220,664,461 |
MARVELD1 | MARVEL domain containing 1 |
83742 | Q9BSK0 | chr10: 97,713,173-97,718,152 |
MAST2 | microtubule associated serine/threonine kinase 2 |
23139 | Q6P0Q8 | chr1: 45,786,987-46,036,124 |
MC2R | melanocortin 2 receptor (adrenocorticotropic hormone) |
4158 | Q01718 | chr18: 13,882,044-13,915,707 |
MC4R | melanocortin 4 receptor |
4160 | P32245 | chr18: 60,371,110-60,372,775 |
MCAM | melanoma cell adhesion molecule |
4162 | P43121 | chr11: 119,308,529-119,321,521 |
MDH2 | malate dehydrogenase 2 |
4191 | P40926 | chr7: 76,048,051-76,067,508 |
MDM2 | MDM2 proto-oncogene, E3 ubiquitin protein ligase |
4193 | Q00987 | chr12: 68,808,176-68,850,686 |
MELK | maternal embryonic leucine zipper kinase |
9833 | Q14680 | chr9: 36,572,862-36,677,683 |
MERTK | MER proto-oncogene, tyrosine kinase |
10461 | Q12866 | chr2: 111,898,479-112,029,561 |
MET | MET proto-oncogene, receptor tyrosine kinase |
4233 | P08581 | chr7: 116,672,390-116,798,386 |
METAP2 | methionyl aminopeptidase 2 |
10988 | P50579 | chr12: 95,473,520-95,515,839 |
MFAP3 | microfibrillar associated protein 3 |
4238 | P55082 | chr5: 154,038,906-154,220,478 |
MFAP3L | microfibrillar associated protein 3 like |
9848 | O75121 | chr4: 169,986,597-170,033,031 |
MFSD2A | major facilitator superfamily domain containing 2A |
84879 | Q8NA29 | chr1: 39,955,112-39,969,968 |
MFSD5 | major facilitator superfamily domain containing 5 |
84975 | Q6N075 | chr12: 53,251,251-53,254,405 |
MGAM | maltase-glucoamylase |
8972 | O43451 | chr7: 141,907,813-142,106,747 |
MGLL | monoglyceride lipase |
11343 | Q99685 | chr3: 127,689,062-127,823,250 |
MGST2 | microsomal glutathione S-transferase 2 |
4258 | Q99735 | chr4: 139,665,768-139,740,745 |
MIB1 | mindbomb E3 ubiquitin protein ligase 1 |
57534 | Q86YT6 | chr18: 21,704,957-21,870,957 |
MICA | MHC class I polypeptide-related sequence A |
100507436 | Q29983 | chr6: 31,399,784-31,415,315 |
MICB | MHC class I polypeptide-related sequence B |
4277 | Q29980 | chr6: 31,494,881-31,511,124 |
MIP | major intrinsic protein of lens fiber |
4284 | P30301 | chr12: 56,449,502-56,469,166 |
MME | membrane metallo-endopeptidase |
4311 | P08473 | chr3: 155,024,124-155,183,729 |
MMP14 | matrix metallopeptidase 14 |
4323 | P50281 | chr14: 22,836,557-22,849,027 |
MMP15 | matrix metallopeptidase 15 |
4324 | P51511 | chr16: 58,025,566-58,046,901 |
MMP16 | matrix metallopeptidase 16 |
4325 | P51512 | chr8: 88,032,009-88,328,025 |
MMP2 | matrix metallopeptidase 2 |
4313 | P08253 | chr16: 55,389,700-55,506,691 |
MMP25 | matrix metallopeptidase 25 |
64386 | Q9NPA2 | chr16: 3,046,681-3,060,726 |
MORF4L2 | mortality factor 4 like 2 |
9643 | Q15014 | chrX: 103,675,496-103,688,158 |
MPHOSPH8 | M-phase phosphoprotein 8 |
54737 | Q99549 | chr13: 19,633,681-19,673,459 |
MPHOSPH9 | M-phase phosphoprotein 9 |
10198 | Q99550 | chr12: 123,152,320-123,244,014 |
MPP5 | membrane protein, palmitoylated 5 |
64398 | Q8N3R9 | chr14: 67,241,109-67,335,819 |
MPP6 | membrane protein, palmitoylated 6 |
51678 | Q9NZW5 | chr7: 24,573,268-24,694,193 |
MR1 | major histocompatibility complex, class I-related |
3140 | Q95460 | chr1: 181,033,425-181,061,938 |
MRAP | melanocortin 2 receptor accessory protein |
56246 | Q8TCY5 | chr21: 32,291,813-32,314,784 |
MRAP2 | melanocortin 2 receptor accessory protein 2 |
112609 | Q96G30 | chr6: 84,033,756-84,090,881 |
MRC1 | mannose receptor, C type 1 |
4360 | P22897 | chr10: 17,809,344-17,911,170 |
MRPL42 | mitochondrial ribosomal protein L42 |
28977 | Q9Y6G3 | chr12: 93,467,488-93,516,213 |
MSH6 | mutS homolog 6 |
2956 | P52701 | chr2: 47,695,530-47,810,101 |
MSMO1 | methylsterol monooxygenase 1 |
6307 | Q15800 | chr4: 165,327,623-165,343,160 |
MT3 | metallothionein 3 |
4504 | P25713 | chr16: 56,589,074-56,591,088 |
MTFR1 | mitochondrial fission regulator 1 |
9650 | Q15390 | chr8: 65,644,734-65,771,261 |
MTM1 | myotubularin 1 |
4534 | Q13496 | chrX: 150,568,619-150,673,322 |
MTMR1 | myotubularin related protein 1 |
8776 | Q13613 | chrX: 150,692,971-150,765,103 |
MTNR1A | melatonin receptor 1A |
4543 | P48039 | chr4: 186,533,655-186,555,567 |
MTNR1B | melatonin receptor 1B |
4544 | P49286 | chr11: 92,969,720-92,985,066 |
MTUS1 | microtubule associated tumor suppressor 1 |
57509 | Q9ULD2 | chr8: 17,643,795-17,800,917 |
MUC15 | mucin 15, cell surface associated |
143662 | Q8N387 | chr11: 26,559,033-26,572,233 |
MUC21 | mucin 21, cell surface associated |
394263 | Q5SSG8 | chr6: 30,983,718-30,989,903 |
MYADM | myeloid-associated differentiation marker |
91663 | Q96S97 | chr19: 53,866,223-53,876,437 |
MYH9 | myosin, heavy chain 9, non-muscle |
4627 | P35579 | chr22: 36,281,281-36,388,018 |
MYLIP | myosin regulatory light chain interacting protein |
29116 | Q8WY64 | chr6: 16,129,125-16,148,248 |
MYO10 | myosin X |
4651 | Q9HD67 | chr5: 16,661,914-16,936,276 |
MYO1C | myosin IC |
4641 | O00159 | chr17: 1,464,098-1,492,812 |
MYO1G | myosin IG |
64005 | B0I1T2 | chr7: 44,962,662-44,979,098 |
MYO6 | myosin VI |
4646 | Q9UM54 | chr6: 75,749,192-75,919,537 |
NAE1 | NEDD8 activating enzyme E1 subunit 1 |
8883 | Q13564 | chr16: 66,802,875-66,873,256 |
NCAM1 | neural cell adhesion molecule 1 |
4684 | P13591 | chr11: 112,961,247-113,278,436 |
NCAM2 | neural cell adhesion molecule 2 |
4685 | O15394 | chr21: 20,998,315-21,543,329 |
NCS1 | neuronal calcium sensor 1 |
23413 | P62166 | chr9: 130,172,578-130,237,304 |
NDC1 | NDC1 transmembrane nucleoporin |
55706 | Q9BTX1 | chr1: 53,765,460-53,838,860 |
NDRG1 | N-myc downstream regulated 1 |
10397 | Q92597 | chr8: 133,237,171-133,302,022 |
NECTIN1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) |
5818 | Q15223 | chr11: 119,623,408-119,729,084 |
NECTIN3 | poliovirus receptor-related 3 |
25945 | Q9NQS3 | chr3: 111,070,071-111,275,563 |
NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
23327 | Q96PU5 | chr18: 58,044,367-58,401,540 |
NET1 | neuroepithelial cell transforming 1 |
10276 | Q7Z628 | chr10: 5,412,551-5,458,463 |
NEU1 | neuraminidase 1 (lysosomal sialidase) |
4758 | Q99519 | chr6: 31,857,659-31,862,906 |
NF2 | neurofibromin 2 (merlin) |
4771 | P35240 | chr22: 29,603,556-29,698,598 |
NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
4773 | Q13469 | chr20: 51,386,957-51,562,831 |
NGFR | nerve growth factor receptor |
4804 | P08138 | chr17: 49,495,293-49,515,017 |
NIPA2 | non imprinted in Prader-Willi/Angelman syndrome 2 |
81614 | Q8N8Q9 | chr15: 22,838,641-22,868,384 |
NISCH | nischarin |
11188 | Q9Y2I1 | chr3: 52,455,118-52,493,071 |
NKAIN1 | Na+/K+ transporting ATPase interacting 1 |
79570 | Q4KMZ8 | chr1: 31,179,745-31,239,554 |
NKAIN2 | Na+/K+ transporting ATPase interacting 2 |
154215 | Q5VXU1 | chr6: 123,804,141-124,825,657 |
NLGN1 | neuroligin 1 |
22871 | Q8N2Q7 | chr3: 173,396,284-174,286,644 |
NLGN4X | neuroligin 4, X-linked |
57502 | Q8N0W4 | chrX: 5,840,637-6,228,863 |
NLN | neurolysin (metallopeptidase M3 family) |
57486 | Q9BYT8 | chr5: 65,722,196-65,871,725 |
NMT2 | N-myristoyltransferase 2 |
9397 | O60551 | chr10: 15,102,584-15,168,693 |
NOS3 | nitric oxide synthase 3 |
4846 | P29474 | chr7: 150,990,995-151,014,588 |
NOSTRIN | nitric oxide synthase trafficking |
115677 | Q8IVI9 | chr2: 168,786,539-168,865,514 |
NOTCH1 | notch 1 |
4851 | P46531 | chr9: 136,494,444-136,545,862 |
NOTCH2 | notch 2 |
4853 | Q04721 | chr1: 119,911,553-120,069,626 |
NPBWR1 | neuropeptides B/W receptor 1 |
2831 | P48145 | chr8: 52,938,431-52,941,117 |
NPEPPS | aminopeptidase puromycin sensitive |
9520 | P55786 | chr17: 47,522,942-47,623,276 |
NPR2 | natriuretic peptide receptor 2 |
4882 | P20594 | chr9: 35,792,154-35,809,732 |
NPR3 | natriuretic peptide receptor 3 |
4883 | P17342 | chr5: 32,689,070-32,791,724 |
NPY1R | neuropeptide Y receptor Y1 |
4886 | P25929 | chr4: 163,323,961-163,344,832 |
NPY2R | neuropeptide Y receptor Y2 |
4887 | P49146 | chr4: 155,208,629-155,217,078 |
NPY5R | neuropeptide Y receptor Y5 |
4889 | Q15761 | chr4: 163,343,939-163,351,934 |
NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 | P01111 | chr1: 114,704,469-114,716,894 |
NRCAM | neuronal cell adhesion molecule |
4897 | Q92823 | chr7: 108,147,623-108,456,717 |
NRN1 | neuritin 1 |
51299 | Q9NPD7 | chr6: 5,997,999-6,007,605 |
NRP1 | neuropilin 1 |
8829 | O14786 | chr10: 33,177,492-33,336,262 |
NRP2 | neuropilin 2 |
8828 | O60462 | chr2: 205,681,990-205,798,133 |
NRXN1 | neurexin 1 |
9378 | Q9ULB1 | chr2: 49,918,505-51,225,575 |
NSF | N-ethylmaleimide sensitive factor |
4905 | P46459 | chr17: 46,590,669-46,757,464 |
NSFL1C | NSFL1 (p97) cofactor (p47) |
55968 | Q9UNZ2 | chr20: 1,442,162-1,473,842 |
NT5E | 5'-nucleotidase, ecto (CD73) |
4907 | P21589 | chr6: 85,449,584-85,495,791 |
NTN4 | netrin 4 |
59277 | Q9HB63 | chr12: 95,657,807-95,791,152 |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 |
4914 | P04629 | chr1: 156,815,640-156,881,850 |
NUCB2 | nucleobindin 2 |
4925 | P80303 | chr11: 17,208,153-17,349,974 |
NUDT1 | nudix hydrolase 1 |
4521 | P36639 | chr7: 2,242,222-2,251,146 |
NUMB | numb homolog (Drosophila) |
8650 | P49757 | chr14: 73,275,107-73,463,642 |
NUP35 | nucleoporin 35kDa |
129401 | Q8NFH5 | chr2: 183,117,513-183,161,680 |
OCLN | occludin |
100506658 | Q16625 | chr5: 69,492,292-69,558,104 |
OCRL | oculocerebrorenal syndrome of Lowe |
4952 | Q01968 | chrX: 129,539,849-129,592,561 |
OGT | O-linked N-acetylglucosamine (GlcNAc) transferase |
8473 | O15294 | chrX: 71,533,083-71,575,897 |
OLFM4 | olfactomedin 4 |
10562 | Q6UX06 | chr13: 53,028,759-53,052,057 |
OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
4973 | P78380 | chr12: 10,158,301-10,172,138 |
OPRL1 | opiate receptor-like 1 |
4987 | P41146 | chr20: 64,080,173-64,100,643 |
OR14C36 | olfactory receptor family 14 subfamily C member 36 |
127066 | Q8NHC7 | chr1: 248,348,775-248,349,713 |
OR2A5 | olfactory receptor family 2 subfamily A member 5 |
393046 | Q96R48 | chr7: 144,048,948-144,058,845 |
OR3A3 | olfactory receptor family 3 subfamily A member 3 |
8392 | P47888 | chr17: 3,411,370-3,424,070 |
OR51E2 | olfactory receptor family 51 subfamily E member 2 |
81285 | Q9H255 | chr11: 4,680,171-4,697,854 |
OR52E8 | olfactory receptor family 52 subfamily E member 8 |
390079 | Q6IFG1 | chr11: 5,856,674-5,857,734 |
OR5A2 | olfactory receptor family 5 subfamily A member 2 |
219981 | Q8NGI9 | chr11: 59,416,969-59,426,412 |
OR5L2 | olfactory receptor family 5 subfamily L member 2 |
26338 | Q8NGL0 | chr11: 55,827,219-55,828,154 |
ORC1 | origin recognition complex subunit 1 |
4998 | Q13415 | chr1: 52,372,829-52,404,459 |
OSBPL6 | oxysterol binding protein like 6 |
114880 | Q9BZF3 | chr2: 178,194,481-178,402,891 |
OSMR | oncostatin M receptor |
9180 | Q99650 | chr5: 38,845,858-38,945,596 |
OXTR | oxytocin receptor |
5021 | P30559 | chr3: 8,750,408-8,769,628 |
P2RX4 | purinergic receptor P2X, ligand gated ion channel, 4 |
5025 | Q99571 | chr12: 121,209,857-121,234,106 |
P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 |
9934 | Q15391 | chr3: 151,212,117-151,278,467 |
P2RY8 | purinergic receptor P2Y, G-protein coupled, 8 |
286530 | Q86VZ1 | chrX: 1,462,572-1,537,107 |
PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 |
29993 | Q9BY11 | chr6: 34,466,061-34,535,231 |
PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 |
5049 | P68402 | chr11: 117,144,267-117,176,894 |
PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 |
55824 | Q9NWQ8 | chr8: 80,967,810-81,112,068 |
PAK1IP1 | PAK1 interacting protein 1 |
55003 | Q9NWT1 | chr6: 10,694,695-10,709,782 |
PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 |
5062 | Q13177 | chr3: 196,739,857-196,832,647 |
PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 |
5063 | O75914 | chrX: 110,944,285-111,227,361 |
PALLD | palladin, cytoskeletal associated protein |
23022 | Q8WX93 | chr4: 168,497,066-168,928,457 |
PALM2 | paralemmin 2 |
114299 | Q8IXS6 | chr9: 109,640,788-109,946,703 |
PAM | peptidylglycine alpha-amidating monooxygenase |
5066 | P19021 | chr5: 102,753,981-103,031,105 |
PANX1 | pannexin 1 |
24145 | Q96RD7 | chr11: 94,128,928-94,181,972 |
PANX2 | pannexin 2 |
56666 | Q96RD6 | chr22: 50,170,731-50,180,294 |
PAQR5 | progestin and adipoQ receptor family member V |
54852 | Q9NXK6 | chr15: 69,298,947-69,407,780 |
PAQR8 | progestin and adipoQ receptor family member VIII |
85315 | Q8TEZ7 | chr6: 52,361,421-52,407,777 |
PARD3 | par-3 family cell polarity regulator |
56288 | Q8TEW0 | chr10: 34,109,560-34,815,325 |
PARD6A | par-6 family cell polarity regulator alpha |
50855 | Q9NPB6 | chr16: 67,660,946-67,662,778 |
PARD6B | par-6 family cell polarity regulator beta |
84612 | Q9BYG5 | chr20: 50,731,544-50,756,795 |
PARM1 | prostate androgen-regulated mucin-like protein 1 |
25849 | Q6UWI2 | chr4: 74,933,095-75,050,115 |
PARVA | parvin alpha |
55742 | Q9NVD7 | chr11: 12,377,185-12,530,801 |
PAWR | PRKC, apoptosis, WT1, regulator |
5074 | Q96IZ0 | chr12: 79,574,979-79,691,097 |
PCDH1 | protocadherin 1 |
5097 | Q08174 | chr5: 141,853,111-141,879,246 |
PCDH10 | protocadherin 10 |
57575 | Q9P2E7 | chr4: 133,149,315-133,208,606 |
PCDH11Y | protocadherin 11 Y-linked |
83259 | Q9BZA8 | chrY: 5,000,226-5,742,224 |
PCDH17 | protocadherin 17 |
27253 | O14917 | chr13: 57,631,810-57,729,311 |
PCDH18 | protocadherin 18 |
54510 | Q9HCL0 | chr4: 137,518,918-137,532,494 |
PCDH19 | protocadherin 19 |
57526 | Q8TAB3 | chrX: 100,291,644-100,410,273 |
PCDH9 | protocadherin 9 |
5101 | Q9HC56 | chr13: 66,302,834-67,230,445 |
PCDHA1 | protocadherin alpha 1 |
56147 | Q9Y5I3 | chr5: 140,786,136-141,012,347 |
PCDHA12 | protocadherin alpha 12 |
56137 | Q9UN75 | chr5: 140,875,302-141,012,344 |
PCDHA13 | protocadherin alpha 13 |
56136 | Q9Y5I0 | chr5: 140,882,208-141,012,344 |
PCDHA9 | protocadherin alpha 9 |
9752 | Q9Y5H5 | chr5: 140,847,463-141,012,344 |
PCDHB14 | protocadherin beta 14 |
56122 | Q9Y5E9 | chr5: 141,222,932-141,227,759 |
PCDHB9 | protocadherin beta 9 |
56127 | Q9Y5E1 | chr5: 141,187,127-141,191,541 |
PCDHGC3 | protocadherin gamma subfamily C, 3 |
5098 | Q9UN70 | chr5: 141,475,947-141,512,979 |
PCSK9 | proprotein convertase subtilisin/kexin type 9 |
255738 | Q8NBP7 | chr1: 55,039,548-55,064,852 |
PCYOX1 | prenylcysteine oxidase 1 |
51449 | Q9UHG3 | chr2: 70,257,386-70,281,191 |
PCYT1A | phosphate cytidylyltransferase 1, choline, alpha |
5130 | P49585 | chr3: 196,214,222-196,287,957 |
PDCD10 | programmed cell death 10 |
11235 | Q9BUL8 | chr3: 167,683,298-167,734,939 |
PDGFC | platelet derived growth factor C |
56034 | Q9NRA1 | chr4: 156,760,454-156,971,394 |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide |
5156 | P16234 | chr4: 54,229,097-54,298,247 |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide |
5159 | P09619 | chr5: 150,113,837-150,155,872 |
PDIA6 | protein disulfide isomerase family A member 6 |
10130 | Q15084 | chr2: 10,783,391-10,837,977 |
PDPN | podoplanin |
10630 | Q86YL7 | chr1: 13,583,465-13,617,957 |
PDS5A | PDS5 cohesin associated factor A |
23244 | Q29RF7 | chr4: 39,822,863-39,977,956 |
PECAM1 | platelet/endothelial cell adhesion molecule 1 |
5175 | P16284 | chr17: 64,319,415-64,413,776 |
PENK | proenkephalin |
5179 | P01210 | chr8: 56,436,674-56,446,734 |
PERP | PERP, TP53 apoptosis effector |
64065 | Q96FX8 | chr6: 138,088,505-138,107,511 |
PHACTR2 | phosphatase and actin regulator 2 |
9749 | O75167 | chr6: 143,536,845-143,831,185 |
PHB | prohibitin |
5245 | P35232 | chr17: 49,404,049-49,414,905 |
PHKA1 | phosphorylase kinase, alpha 1 (muscle) |
5255 | P46020 | chrX: 72,578,814-72,714,319 |
PHKA2 | phosphorylase kinase, alpha 2 (liver) |
5256 | P46019 | chrX: 18,892,300-18,984,598 |
PHLDB2 | pleckstrin homology-like domain, family B, member 2 |
90102 | Q86SQ0 | chr3: 111,732,497-111,976,517 |
PIEZO1 | piezo-type mechanosensitive ion channel component 1 |
9780 | Q92508 | chr16: 88,715,343-88,785,211 |
PIGU | phosphatidylinositol glycan anchor biosynthesis class U |
128869 | Q9H490 | chr20: 34,560,542-34,698,790 |
PIGY | phosphatidylinositol glycan anchor biosynthesis class Y |
84992 | Q3MUY2 | chr4: 88,521,048-88,708,542 |
PIK3C2A | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha |
5286 | O00443 | chr11: 17,077,730-17,207,983 |
PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 | P42336 | chr3: 179,148,114-179,240,093 |
PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 | P42338 | chr3: 138,652,699-138,834,938 |
PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 | O00329 | chr1: 9,651,732-9,729,114 |
PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
5294 | P48736 | chr7: 106,865,278-106,907,145 |
PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
5295 | P27986 | chr5: 68,215,720-68,301,821 |
PIP4K2B | phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
8396 | P78356 | chr17: 38,765,689-38,800,126 |
PKD1 | polycystic kidney disease 1 (autosomal dominant) |
5310 | P98161 | chr16: 2,088,710-2,135,898 |
PKD2 | polycystic kidney disease 2 (autosomal dominant) |
5311 | Q13563 | chr4: 88,007,668-88,077,777 |
PKM | pyruvate kinase, muscle |
5315 | P14618 | chr15: 72,199,029-72,231,822 |
PKN1 | protein kinase N1 |
5585 | Q16512 | chr19: 14,433,053-14,471,867 |
PKN2 | protein kinase N2 |
5586 | Q16513 | chr1: 88,684,222-88,836,255 |
PKP2 | plakophilin 2 |
5318 | Q99959 | chr12: 32,790,745-32,896,840 |
PKP3 | plakophilin 3 |
11187 | Q9Y446 | chr11: 392,614-404,908 |
PKP4 | plakophilin 4 |
8502 | Q99569 | chr2: 158,456,964-158,682,879 |
PLA2G2A | phospholipase A2 group IIA |
5320 | P14555 | chr1: 19,975,431-19,980,416 |
PLA2G5 | phospholipase A2 group V |
5322 | P39877 | chr1: 20,028,179-20,091,190 |
PLAU | plasminogen activator, urokinase |
5328 | P00749 | chr10: 73,909,177-73,917,497 |
PLAUR | plasminogen activator, urokinase receptor |
5329 | Q03405 | chr19: 43,646,095-43,670,547 |
PLCD1 | phospholipase C delta 1 |
5333 | P51178 | chr3: 38,007,496-38,029,762 |
PLCG2 | phospholipase C gamma 2 |
5336 | P16885 | chr16: 81,739,097-81,962,693 |
PLCL1 | phospholipase C like 1 |
5334 | Q15111 | chr2: 197,804,702-198,572,581 |
PLEKHA2 | pleckstrin homology domain containing A2 |
59339 | Q9HB19 | chr8: 38,901,235-38,973,909 |
PLEKHG5 | pleckstrin homology and RhoGEF domain containing G5 |
57449 | O94827 | chr1: 6,466,092-6,520,061 |
PLEKHH2 | pleckstrin homology, MyTH4 and FERM domain containing H2 |
130271 | Q8IVE3 | chr2: 43,637,273-43,767,987 |
PLG | plasminogen |
5340 | P00747 | chr6: 160,702,238-160,753,315 |
PLIN2 | perilipin 2 |
123 | Q99541 | chr9: 19,108,375-19,149,290 |
PLIN4 | perilipin 4 |
729359 | Q96Q06 | chr19: 4,502,180-4,518,465 |
PLP1 | proteolipid protein 1 |
5354 | P60201 | chrX: 103,773,718-103,792,619 |
PLPP1 | phospholipid phosphatase 1 |
8611 | O14494 | chr5: 55,424,854-55,535,050 |
PLPP3 | phospholipid phosphatase 3 |
8613 | O14495 | chr1: 56,494,747-56,645,301 |
PLPP5 | phospholipid phosphatase 5 |
84513 | Q8NEB5 | chr8: 38,263,130-38,269,243 |
PLPPR4 | phospholipid phosphatase related 4 |
9890 | Q7Z2D5 | chr1: 99,263,953-99,309,590 |
PLSCR1 | phospholipid scramblase 1 |
5359 | O15162 | chr3: 146,515,180-146,544,864 |
PLSCR4 | phospholipid scramblase 4 |
57088 | Q9NRQ2 | chr3: 146,192,339-146,251,179 |
PLXNA1 | plexin A1 |
5361 | Q9UIW2 | chr3: 126,988,594-127,037,392 |
PLXNA2 | plexin A2 |
5362 | O75051 | chr1: 208,022,242-208,244,320 |
PLXNA3 | plexin A3 |
55558 | P51805 | chrX: 154,458,281-154,477,779 |
PLXNC1 | plexin C1 |
10154 | O60486 | chr12: 94,148,723-94,307,675 |
PLXND1 | plexin D1 |
23129 | Q9Y4D7 | chr3: 129,555,175-129,606,818 |
PMEL | premelanosome protein |
6490 | P40967 | chr12: 55,954,105-55,973,317 |
PMEPA1 | prostate transmembrane protein, androgen induced 1 |
56937 | Q969W9 | chr20: 57,648,392-57,711,536 |
PMP22 | peripheral myelin protein 22 |
5376 | Q01453 | chr17: 15,229,777-15,265,326 |
PNN | pinin, desmosome associated protein |
5411 | Q9H307 | chr14: 39,175,183-39,183,218 |
PNPLA2 | patatin like phospholipase domain containing 2 |
57104 | Q96AD5 | chr11: 818,902-825,573 |
POLE | polymerase (DNA directed), epsilon, catalytic subunit |
5426 | Q07864 | chr12: 132,623,753-132,687,365 |
PPIL2 | peptidylprolyl isomerase like 2 |
23759 | Q13356 | chr22: 21,666,009-21,700,015 |
PPIP5K1 | diphosphoinositol pentakisphosphate kinase 1 |
9677 | Q6PFW1 | chr15: 43,533,462-43,590,253 |
PPL | periplakin |
5493 | O60437 | chr16: 4,882,507-4,960,741 |
PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme |
5499 | P62136 | chr11: 67,398,183-67,421,183 |
PPP1R12B | protein phosphatase 1 regulatory subunit 12B |
4660 | O60237 | chr1: 202,348,699-202,592,706 |
PPP4C | protein phosphatase 4 catalytic subunit |
5531 | P60510 | chr16: 30,075,978-30,085,377 |
PRC1 | protein regulator of cytokinesis 1 |
9055 | O43663 | chr15: 90,966,038-90,995,629 |
PREX2 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
80243 | Q70Z35 | chr8: 67,952,118-68,237,030 |
PRKAR2A | protein kinase, cAMP-dependent, regulatory subunit type II alpha |
5576 | P13861 | chr3: 48,744,597-48,847,846 |
PRKAR2B | protein kinase, cAMP-dependent, regulatory subunit type II beta |
5577 | P31323 | chr7: 107,044,649-107,161,811 |
PRKCA | protein kinase C, alpha |
5578 | P17252 | chr17: 66,302,636-66,810,743 |
PRKCB | protein kinase C, beta |
5579 | P05771 | chr16: 23,836,001-24,220,611 |
PRKCD | protein kinase C, delta |
5580 | Q05655 | chr3: 53,156,009-53,192,717 |
PRKCI | protein kinase C, iota |
5584 | P41743 | chr3: 170,222,365-170,305,981 |
PRKCQ | protein kinase C, theta |
5588 | Q04759 | chr10: 6,427,143-6,580,301 |
PRKD1 | protein kinase D1 |
5587 | Q15139 | chr14: 29,576,479-30,191,898 |
PRKD2 | protein kinase D2 |
25865 | Q9BZL6 | chr19: 46,674,275-46,717,127 |
PRLR | prolactin receptor |
5618 | P16471 | chr5: 35,048,756-35,230,589 |
PRND | prion protein 2 (dublet) |
23627 | Q9UKY0 | chr20: 4,721,910-4,728,460 |
PRNP | prion protein |
5621 | P04156 | chr20: 4,686,236-4,701,590 |
PROCR | protein C receptor |
10544 | Q9UNN8 | chr20: 35,172,073-35,216,240 |
PRRT1 | proline-rich transmembrane protein 1 |
80863 | Q99946 | chr6: 32,148,359-32,154,373 |
PRSS12 | protease, serine 12 |
8492 | P56730 | chr4: 118,280,038-118,353,003 |
PSEN1 | presenilin 1 |
5663 | P49768 | chr14: 73,136,418-73,223,691 |
PSEN2 | presenilin 2 |
5664 | P49810 | chr1: 226,870,184-226,896,105 |
PSKH1 | protein serine kinase H1 |
5681 | P11801 | chr16: 67,893,272-67,929,678 |
PTAFR | platelet-activating factor receptor |
5724 | P25105 | chr1: 28,147,166-28,193,936 |
PTCH1 | patched 1 |
5727 | Q13635 | chr9: 95,442,980-95,517,057 |
PTCHD1 | patched domain containing 1 |
139411 | Q96NR3 | chrX: 23,334,016-23,404,372 |
PTEN | phosphatase and tensin homolog |
5728 | P60484 | chr10: 87,863,113-87,971,930 |
PTGDR | prostaglandin D2 receptor (DP) |
5729 | Q13258 | chr14: 52,267,713-52,276,724 |
PTGER2 | prostaglandin E receptor 2 |
5732 | P43116 | chr14: 52,314,305-52,328,606 |
PTGER3 | prostaglandin E receptor 3 |
5733 | P43115 | chr1: 70,852,353-71,047,808 |
PTGER4 | prostaglandin E receptor 4 |
5734 | P35408 | chr5: 40,679,498-40,693,735 |
PTGFR | prostaglandin F receptor (FP) |
5737 | P43088 | chr1: 78,303,884-78,539,749 |
PTH2R | parathyroid hormone 2 receptor |
5746 | P49190 | chr2: 208,359,714-208,854,503 |
PTK2 | protein tyrosine kinase 2 |
5747 | Q05397 | chr8: 140,657,900-141,002,216 |
PTP4A2 | protein tyrosine phosphatase type IVA, member 2 |
8073 | Q12974 | chr1: 31,906,421-31,944,856 |
PTPN2 | protein tyrosine phosphatase, non-receptor type 2 |
5771 | P17706 | chr18: 12,785,478-12,929,643 |
PTPRC | protein tyrosine phosphatase, receptor type, C |
5788 | P08575 | chr1: 198,638,671-198,757,283 |
PTPRD | protein tyrosine phosphatase, receptor type, D |
5789 | P23468 | chr9: 8,314,246-10,612,723 |
PTPRF | protein tyrosine phosphatase, receptor type, F |
5792 | P10586 | chr1: 43,525,187-43,623,666 |
PTPRJ | protein tyrosine phosphatase, receptor type, J |
5795 | Q12913 | chr11: 47,980,558-48,170,841 |
PTPRO | protein tyrosine phosphatase, receptor type, O |
5800 | Q16827 | chr12: 15,322,397-15,597,399 |
PVR | poliovirus receptor |
5817 | P15151 | chr19: 44,643,798-44,663,583 |
PXK | PX domain containing serine/threonine kinase |
54899 | Q7Z7A4 | chr3: 58,332,880-58,426,126 |
QSOX2 | quiescin sulfhydryl oxidase 2 |
169714 | Q6ZRP7 | chr9: 136,206,333-136,245,841 |
RAB11A | RAB11A, member RAS oncogene family |
8766 | P62491 | chr15: 65,726,054-65,891,991 |
RAB11B | RAB11B, member RAS oncogene family |
9230 | Q15907 | chr19: 8,389,981-8,404,434 |
RAB11FIP2 | RAB11 family interacting protein 2 (class I) |
22841 | Q7L804 | chr10: 118,004,916-118,046,603 |
RAB22A | RAB22A, member RAS oncogene family |
57403 | Q9UL26 | chr20: 58,309,696-58,367,507 |
RAB23 | RAB23, member RAS oncogene family |
51715 | Q9ULC3 | chr6: 57,186,992-57,222,314 |
RAB28 | RAB28, member RAS oncogene family |
9364 | P51157 | chr4: 13,361,354-13,484,365 |
RAB29 | RAB29, member RAS oncogene family |
8934 | O14966 | chr1: 205,767,986-205,775,460 |
RAB2B | RAB2B, member RAS oncogene family |
84932 | Q8WUD1 | chr14: 21,459,020-21,476,973 |
RAB33A | RAB33A, member RAS oncogene family |
9363 | Q14088 | chrX: 130,171,649-130,184,870 |
RAB39B | RAB39B, member RAS oncogene family |
116442 | Q96DA2 | chrX: 155,258,241-155,264,589 |
RAB3B | RAB3B, member RAS oncogene family |
5865 | P20337 | chr1: 51,907,956-51,990,764 |
RAB3GAP2 | RAB3 GTPase activating non-catalytic protein subunit 2 |
25782 | Q9H2M9 | chr1: 220,148,293-220,272,454 |
RAB40B | RAB40B, member RAS oncogene family |
10966 | Q12829 | chr17: 82,654,973-82,698,728 |
RAB4B | RAB4B, member RAS oncogene family |
53916 | P61018 | chr19: 40,778,216-40,796,938 |
RAB5A | RAB5A, member RAS oncogene family |
5868 | P20339 | chr3: 19,947,079-19,985,175 |
RAB5B | RAB5B, member RAS oncogene family |
5869 | P61020 | chr12: 55,973,913-55,996,683 |
RAB5C | RAB5C, member RAS oncogene family |
5878 | P51148 | chr17: 42,124,976-42,155,044 |
RAB8B | RAB8B, member RAS oncogene family |
51762 | Q92930 | chr15: 63,189,469-63,267,782 |
RAB9A | RAB9A, member RAS oncogene family |
9367 | P51151 | chrX: 13,689,125-13,710,506 |
RABEPK | Rab9 effector protein with kelch motifs |
10244 | Q7Z6M1 | chr9: 125,200,542-125,234,158 |
RABGGTB | Rab geranylgeranyltransferase, beta subunit |
5876 | P53611 | chr1: 75,786,197-75,795,079 |
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
5879 | P63000 | chr7: 6,374,523-6,403,977 |
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
5880 | P15153 | chr22: 37,225,261-37,244,448 |
RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
5881 | P60763 | chr17: 82,031,624-82,034,204 |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase |
5894 | P04049 | chr3: 12,583,601-12,664,226 |
RALA | v-ral simian leukemia viral oncogene homolog A (ras related) |
5898 | P11233 | chr7: 39,623,483-39,708,124 |
RALB | v-ral simian leukemia viral oncogene homolog B |
5899 | P11234 | chr2: 120,240,064-120,294,713 |
RALGAPA2 | Ral GTPase activating protein, alpha subunit 2 (catalytic) |
57186 | Q2PPJ7 | chr20: 20,389,552-20,712,488 |
RALGPS1 | Ral GEF with PH domain and SH3 binding motif 1 |
9649 | Q5JS13 | chr9: 126,914,774-127,223,166 |
RALGPS2 | Ral GEF with PH domain and SH3 binding motif 2 |
55103 | Q86X27 | chr1: 178,725,147-178,921,841 |
RAMP1 | receptor (G protein-coupled) activity modifying protein 1 |
10267 | O60894 | chr2: 237,858,893-237,912,114 |
RAMP3 | receptor (G protein-coupled) activity modifying protein 3 |
10268 | O60896 | chr7: 45,157,791-45,186,302 |
RANBP9 | RAN binding protein 9 |
10048 | Q96S59 | chr6: 13,621,498-13,711,564 |
RANGRF | RAN guanine nucleotide release factor |
29098 | Q9HD47 | chr17: 8,288,497-8,290,092 |
RAP1A | RAP1A, member of RAS oncogene family |
5906 | P62834 | chr1: 111,542,218-111,716,691 |
RAP2A | RAP2A, member of RAS oncogene family |
5911 | P10114 | chr13: 97,434,222-97,469,128 |
RAP2B | RAP2B, member of RAS oncogene family |
5912 | P61225 | chr3: 153,162,270-153,170,620 |
RAPGEF4 | Rap guanine nucleotide exchange factor 4 |
11069 | Q8WZA2 | chr2: 172,735,274-173,052,893 |
RAPGEF6 | Rap guanine nucleotide exchange factor 6 |
51735 | Q8TEU7 | chr5: 131,423,921-131,635,236 |
RAPH1 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
65059 | Q70E73 | chr2: 203,394,345-203,535,410 |
RASA4 | RAS p21 protein activator 4 |
10156 | O43374 | chr7: 102,573,807-102,616,757 |
RASD1 | RAS, dexamethasone-induced 1 |
51655 | Q9Y272 | chr17: 17,494,437-17,496,395 |
RASD2 | RASD family member 2 |
23551 | Q96D21 | chr22: 35,540,868-35,554,001 |
RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
10235 | Q7LDG7 | chr11: 64,726,911-64,745,456 |
RASL10B | RAS-like family 10 member B |
91608 | Q96S79 | chr17: 35,731,649-35,743,521 |
RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 |
11186 | Q9NS23 | chr3: 50,329,782-50,340,980 |
RASSF3 | Ras association (RalGDS/AF-6) domain family member 3 |
283349 | Q86WH2 | chr12: 64,507,001-64,697,567 |
RDX | radixin |
5962 | P35241 | chr11: 110,174,880-110,296,722 |
RECK | reversion-inducing-cysteine-rich protein with kazal motifs |
8434 | O95980 | chr9: 36,036,433-36,124,451 |
RELL1 | RELT-like 1 |
768211 | Q8IUW5 | chr4: 37,590,800-37,686,376 |
REPS1 | RALBP1 associated Eps domain containing 1 |
85021 | Q96D71 | chr6: 138,903,493-138,988,261 |
RFFL | ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
117584 | Q8WZ73 | chr17: 35,005,990-35,089,319 |
RFTN1 | raftlin, lipid raft linker 1 |
23180 | Q14699 | chr3: 16,313,574-16,514,026 |
RFTN2 | raftlin family member 2 |
130132 | Q52LD8 | chr2: 197,568,224-197,676,045 |
RGMB | repulsive guidance molecule family member b |
285704 | Q6NW40 | chr5: 98,768,650-98,798,643 |
RGS10 | regulator of G-protein signaling 10 |
6001 | O43665 | chr10: 119,499,828-119,542,708 |
RGS12 | regulator of G-protein signaling 12 |
6002 | O14924 | chr4: 3,293,028-3,439,913 |
RGS2 | regulator of G-protein signaling 2 |
5997 | P41220 | chr1: 192,809,039-192,812,283 |
RGS22 | regulator of G-protein signaling 22 |
26166 | Q8NE09 | chr8: 99,960,936-100,131,268 |
RGS3 | regulator of G-protein signaling 3 |
5998 | P49796 | chr9: 113,444,731-113,597,743 |
RGS4 | regulator of G-protein signaling 4 |
5999 | P49798 | chr1: 163,068,775-163,076,802 |
RGS5 | regulator of G-protein signaling 5 |
8490 | O15539 | chr1: 163,111,121-163,321,791 |
RGS7 | regulator of G-protein signaling 7 |
6000 | P49802 | chr1: 240,775,515-241,357,230 |
RGS7BP | regulator of G-protein signaling 7 binding protein |
401190 | Q6MZT1 | chr5: 64,506,257-64,612,312 |
RHBG | Rh family, B glycoprotein (gene/pseudogene) |
57127 | Q9H310 | chr1: 156,369,212-156,385,219 |
RHOA | ras homolog family member A |
387 | P61586 | chr3: 49,359,145-49,412,998 |
RHOB | ras homolog family member B |
388 | P62745 | chr2: 20,447,074-20,449,445 |
RHOD | ras homolog family member D |
29984 | O00212 | chr11: 67,056,818-67,072,013 |
RHOJ | ras homolog family member J |
57381 | Q9H4E5 | chr14: 63,204,114-63,293,219 |
RHOQ | ras homolog family member Q |
23433 | P17081 | chr2: 46,541,806-46,583,121 |
RHOU | ras homolog family member U |
58480 | Q7L0Q8 | chr1: 228,735,077-228,746,669 |
RIF1 | replication timing regulatory factor 1 |
55183 | Q5UIP0 | chr2: 151,409,883-151,508,013 |
RIT1 | Ras-like without CAAX 1 |
6016 | Q92963 | chr1: 155,897,808-155,911,404 |
RNF144A | ring finger protein 144A |
9781 | P50876 | chr2: 6,917,392-7,068,286 |
ROCK2 | Rho-associated, coiled-coil containing protein kinase 2 |
9475 | O75116 | chr2: 11,179,761-11,348,330 |
ROR1 | receptor tyrosine kinase-like orphan receptor 1 |
4919 | Q01973 | chr1: 63,774,022-64,181,498 |
RP2 | retinitis pigmentosa 2 (X-linked recessive) |
6102 | O75695 | chrX: 46,836,940-46,882,358 |
RPH3AL | rabphilin 3A-like (without C2 domains) |
9501 | Q9UNE2 | chr17: 212,389-386,254 |
RPS27A | ribosomal protein S27a |
6233 | P62979 | chr2: 55,231,903-55,235,853 |
RPSA | ribosomal protein SA |
3921 | P08865 | chr3: 39,406,689-39,412,542 |
RRAD | Ras-related associated with diabetes |
6236 | P55042 | chr16: 66,921,679-66,925,644 |
RRAS | related RAS viral (r-ras) oncogene homolog |
6237 | P10301 | chr19: 49,635,292-49,640,201 |
RRAS2 | related RAS viral (r-ras) oncogene homolog 2 |
22800 | P62070 | chr11: 14,277,926-14,364,506 |
RTN4 | reticulon 4 |
57142 | Q9NQC3 | chr2: 54,972,187-55,112,621 |
RYR2 | ryanodine receptor 2 (cardiac) |
6262 | Q92736 | chr1: 237,042,205-237,833,988 |
S100A16 | S100 calcium binding protein A16 |
140576 | Q96FQ6 | chr1: 153,606,886-153,613,145 |
S100A8 | S100 calcium binding protein A8 |
6279 | P05109 | chr1: 153,390,032-153,391,188 |
S100A9 | S100 calcium binding protein A9 |
6280 | P06702 | chr1: 153,357,854-153,361,027 |
S1PR1 | sphingosine-1-phosphate receptor 1 |
1901 | P21453 | chr1: 101,236,888-101,241,518 |
S1PR3 | sphingosine-1-phosphate receptor 3 |
1903 | Q99500 | chr9: 88,991,447-89,005,010 |
SAMHD1 | SAM domain and HD domain 1 |
25939 | Q9Y3Z3 | chr20: 36,890,229-36,951,843 |
SCARB1 | scavenger receptor class B member 1 |
949 | Q8WTV0 | chr12: 124,776,856-124,882,668 |
SCARF1 | scavenger receptor class F member 1 |
8578 | Q14162 | chr17: 1,633,858-1,645,747 |
SCNN1A | sodium channel, non voltage gated 1 alpha subunit |
6337 | P37088 | chr12: 6,346,843-6,377,730 |
SCNN1G | sodium channel, non voltage gated 1 gamma subunit |
6340 | P51170 | chr16: 23,182,715-23,216,883 |
SDC1 | syndecan 1 |
6382 | P18827 | chr2: 20,200,797-20,225,433 |
SDC2 | syndecan 2 |
6383 | P34741 | chr8: 96,493,351-96,611,780 |
SDC3 | syndecan 3 |
9672 | O75056 | chr1: 30,869,467-30,908,761 |
SDC4 | syndecan 4 |
6385 | P31431 | chr20: 45,325,288-45,348,424 |
SDCBP | syndecan binding protein |
6386 | O00560 | chr8: 58,552,924-58,582,860 |
SDCBP2 | syndecan binding protein 2 |
27111 | Q9H190 | chr20: 1,309,909-1,329,239 |
SDF4 | stromal cell derived factor 4 |
51150 | Q9BRK5 | chr1: 1,216,908-1,232,031 |
SDHB | succinate dehydrogenase complex subunit B, iron sulfur (Ip) |
6390 | P21912 | chr1: 17,018,722-17,054,170 |
SDK1 | sidekick cell adhesion molecule 1 |
221935 | Q7Z5N4 | chr7: 3,301,448-4,269,000 |
SDK2 | sidekick cell adhesion molecule 2 |
54549 | Q58EX2 | chr17: 73,334,384-73,644,089 |
SECTM1 | secreted and transmembrane 1 |
6398 | Q8WVN6 | chr17: 82,321,024-82,334,074 |
SELE | selectin E |
6401 | P16581 | chr1: 169,722,641-169,764,705 |
SELL | selectin L |
6402 | P14151 | chr1: 169,690,667-169,711,698 |
SELPLG | selectin P ligand |
6404 | Q14242 | chr12: 108,622,277-108,633,959 |
SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
64218 | Q9H3S1 | chr1: 156,147,366-156,177,752 |
SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
9037 | Q13591 | chr5: 9,035,026-9,546,075 |
SEMA6D | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
80031 | Q8NFY4 | chr15: 47,184,101-47,774,223 |
SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
8482 | O75326 | chr15: 74,409,289-74,434,467 |
SEPHS1 | selenophosphate synthetase 1 |
22929 | P49903 | chr10: 13,317,424-13,348,298 |
SEPT7 | septin 7 |
989 | Q16181 | chr7: 35,800,932-35,907,105 |
SERBP1 | SERPINE1 mRNA binding protein 1 |
26135 | Q8NC51 | chr1: 67,407,810-67,430,415 |
SERINC1 | serine incorporator 1 |
57515 | Q9NRX5 | chr6: 122,443,354-122,471,822 |
SERINC3 | serine incorporator 3 |
10955 | Q13530 | chr20: 44,496,221-44,522,109 |
SERINC5 | serine incorporator 5 |
256987 | Q86VE9 | chr5: 80,111,651-80,256,079 |
SERPINA12 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
145264 | Q8IW75 | chr14: 94,487,274-94,517,844 |
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 |
462 | P01008 | chr1: 173,903,804-173,917,378 |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 | P05121 | chr7: 101,127,089-101,139,266 |
SEZ6L2 | seizure related 6 homolog (mouse)-like 2 |
26470 | Q6UXD5 | chr16: 29,871,159-29,899,547 |
SFRP1 | secreted frizzled-related protein 1 |
6422 | Q8N474 | chr8: 41,261,958-41,309,497 |
SGCD | sarcoglycan delta |
6444 | Q92629 | chr5: 155,870,344-156,767,788 |
SGMS1 | sphingomyelin synthase 1 |
259230 | Q86VZ5 | chr10: 50,305,586-50,625,163 |
SGMS2 | sphingomyelin synthase 2 |
166929 | Q8NHU3 | chr4: 107,824,563-107,915,047 |
SH3GL2 | SH3-domain GRB2-like 2 |
6456 | Q99962 | chr9: 17,579,082-17,797,129 |
SH3TC2 | SH3 domain and tetratricopeptide repeats 2 |
79628 | Q8TF17 | chr5: 148,923,639-149,063,163 |
SHB | Src homology 2 domain containing adaptor protein B |
6461 | Q15464 | chr9: 37,919,134-38,069,211 |
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 |
25759 | P98077 | chr19: 416,583-460,996 |
SHROOM2 | shroom family member 2 |
357 | Q13796 | chrX: 9,786,456-9,949,443 |
SIAH1 | siah E3 ubiquitin protein ligase 1 |
6477 | Q8IUQ4 | chr16: 48,356,364-48,448,402 |
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin |
6614 | Q9BZZ2 | chr20: 3,686,970-3,707,128 |
SIGLEC7 | sialic acid binding Ig-like lectin 7 |
27036 | Q9Y286 | chr19: 51,142,299-51,153,526 |
SIRPA | signal-regulatory protein alpha |
140885 | P78324 | chr20: 1,894,167-1,940,592 |
SIRT2 | sirtuin 2 |
22933 | Q8IXJ6 | chr19: 38,878,555-38,899,862 |
SKAP2 | src kinase associated phosphoprotein 2 |
8935 | O75563 | chr7: 26,667,062-26,995,239 |
SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
6556 | P49279 | chr2: 218,382,029-218,396,894 |
SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
4891 | P49281 | chr12: 50,979,401-51,028,566 |
SLC12A2 | solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
6558 | P55011 | chr5: 128,083,766-128,189,688 |
SLC14A1 | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) |
6563 | Q13336 | chr18: 45,724,127-45,752,520 |
SLC15A2 | solute carrier family 15 (oligopeptide transporter), member 2 |
6565 | Q16348 | chr3: 121,894,089-121,944,102 |
SLC16A10 | solute carrier family 16 (aromatic amino acid transporter), member 10 |
117247 | Q8TF71 | chr6: 111,087,503-111,231,194 |
SLC16A14 | solute carrier family 16 member 14 |
151473 | Q7RTX9 | chr2: 230,034,974-230,068,999 |
SLC16A3 | solute carrier family 16 (monocarboxylate transporter), member 3 |
9123 | O15427 | chr17: 82,228,397-82,261,129 |
SLC16A7 | solute carrier family 16 (monocarboxylate transporter), member 7 |
9194 | O60669 | chr12: 59,596,067-59,789,855 |
SLC16A9 | solute carrier family 16 member 9 |
220963 | Q7RTY1 | chr10: 59,650,761-59,736,002 |
SLC18A2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
6571 | Q05940 | chr10: 117,241,093-117,279,430 |
SLC19A1 | solute carrier family 19 (folate transporter), member 1 |
6573 | P41440 | chr21: 45,493,572-45,544,411 |
SLC19A2 | solute carrier family 19 (thiamine transporter), member 2 |
10560 | O60779 | chr1: 169,463,909-169,486,003 |
SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
6506 | P43004 | chr11: 35,251,206-35,420,063 |
SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
6507 | P43003 | chr5: 36,606,355-36,688,334 |
SLC1A4 | solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
6509 | P43007 | chr2: 64,988,477-65,023,865 |
SLC1A5 | solute carrier family 1 (neutral amino acid transporter), member 5 |
6510 | Q15758 | chr19: 46,774,883-46,788,594 |
SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
6511 | P48664 | chr19: 14,950,034-15,022,990 |
SLC20A1 | solute carrier family 20 (phosphate transporter), member 1 |
6574 | Q8WUM9 | chr2: 112,645,857-112,663,827 |
SLC20A2 | solute carrier family 20 (phosphate transporter), member 2 |
6575 | Q08357 | chr8: 42,416,475-42,541,926 |
SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 |
6580 | O15245 | chr6: 160,121,789-160,158,718 |
SLC22A18 | solute carrier family 22 member 18 |
5002 | Q96BI1 | chr11: 2,899,721-2,925,246 |
SLC22A3 | solute carrier family 22 (organic cation transporter), member 3 |
6581 | O75751 | chr6: 160,348,268-160,452,581 |
SLC22A5 | solute carrier family 22 (organic cation/carnitine transporter), member 5 |
6584 | O76082 | chr5: 132,369,752-132,395,614 |
SLC23A2 | solute carrier family 23 (ascorbic acid transporter), member 2 |
9962 | Q9UGH3 | chr20: 4,852,356-5,010,293 |
SLC24A3 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
57419 | Q9HC58 | chr20: 19,212,646-19,722,937 |
SLC26A1 | solute carrier family 26 (anion exchanger), member 1 |
10861 | Q9H2B4 | chr4: 979,073-993,440 |
SLC26A11 | solute carrier family 26 (anion exchanger), member 11 |
284129 | Q86WA9 | chr17: 80,219,699-80,253,500 |
SLC26A2 | solute carrier family 26 (anion exchanger), member 2 |
1836 | P50443 | chr5: 149,960,737-149,993,455 |
SLC27A1 | solute carrier family 27 (fatty acid transporter), member 1 |
376497 | Q6PCB7 | chr19: 17,468,769-17,506,168 |
SLC27A4 | solute carrier family 27 (fatty acid transporter), member 4 |
10999 | Q6P1M0 | chr9: 128,340,646-128,361,470 |
SLC27A6 | solute carrier family 27 (fatty acid transporter), member 6 |
28965 | Q9Y2P4 | chr5: 128,538,013-129,033,642 |
SLC28A3 | solute carrier family 28 (concentrative nucleoside transporter), member 3 |
64078 | Q9HAS3 | chr9: 84,275,457-84,340,683 |
SLC29A1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
2030 | Q99808 | chr6: 44,219,505-44,234,151 |
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
6513 | P11166 | chr1: 42,925,375-42,959,173 |
SLC2A10 | solute carrier family 2 (facilitated glucose transporter), member 10 |
81031 | O95528 | chr20: 46,709,487-46,736,347 |
SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
6515 | P11169 | chr12: 7,919,230-7,936,275 |
SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
6517 | P14672 | chr17: 7,281,667-7,288,257 |
SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
6518 | P22732 | chr1: 9,035,107-9,088,478 |
SLC2A6 | solute carrier family 2 (facilitated glucose transporter), member 6 |
11182 | Q9UGQ3 | chr9: 133,471,095-133,479,137 |
SLC30A1 | solute carrier family 30 (zinc transporter), member 1 |
7779 | Q9Y6M5 | chr1: 211,571,568-211,578,742 |
SLC30A8 | solute carrier family 30 (zinc transporter), member 8 |
169026 | Q8IWU4 | chr8: 116,950,273-117,176,714 |
SLC31A1 | solute carrier family 31 (copper transporter), member 1 |
1317 | O15431 | chr9: 113,221,562-113,264,492 |
SLC35G2 | solute carrier family 35 member G2 |
80723 | Q8TBE7 | chr3: 136,818,647-136,855,892 |
SLC36A1 | solute carrier family 36 (proton/amino acid symporter), member 1 |
206358 | Q7Z2H8 | chr5: 151,437,046-151,492,381 |
SLC38A1 | solute carrier family 38 member 1 |
81539 | Q9H2H9 | chr12: 46,183,063-46,270,017 |
SLC38A5 | solute carrier family 38 member 5 |
92745 | Q8WUX1 | chrX: 48,458,537-48,470,256 |
SLC39A14 | solute carrier family 39 (zinc transporter), member 14 |
23516 | Q15043 | chr8: 22,367,249-22,434,129 |
SLC39A4 | solute carrier family 39 (zinc transporter), member 4 |
55630 | Q6P5W5 | chr8: 144,409,742-144,416,895 |
SLC39A6 | solute carrier family 39 (zinc transporter), member 6 |
25800 | Q13433 | chr18: 36,108,532-36,129,385 |
SLC39A8 | solute carrier family 39 (zinc transporter), member 8 |
64116 | Q9C0K1 | chr4: 102,251,041-102,431,258 |
SLC3A2 | solute carrier family 3 (amino acid transporter heavy chain), member 2 |
6520 | P08195 | chr11: 62,856,102-62,888,875 |
SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 |
30061 | Q9NP59 | chr2: 189,560,579-189,583,758 |
SLC41A2 | solute carrier family 41 (magnesium transporter), member 2 |
84102 | Q96JW4 | chr12: 104,802,553-104,958,744 |
SLC41A3 | solute carrier family 41 member 3 |
54946 | Q96GZ6 | chr3: 126,006,355-126,101,561 |
SLC44A1 | solute carrier family 44 (choline transporter), member 1 |
23446 | Q8WWI5 | chr9: 105,244,622-105,439,171 |
SLC44A2 | solute carrier family 44 (choline transporter), member 2 |
57153 | Q8IWA5 | chr19: 10,602,457-10,644,559 |
SLC44A3 | solute carrier family 44 member 3 |
126969 | Q8N4M1 | chr1: 94,820,342-94,895,246 |
SLC44A5 | solute carrier family 44 member 5 |
204962 | Q8NCS7 | chr1: 75,202,131-75,611,116 |
SLC46A1 | solute carrier family 46 (folate transporter), member 1 |
113235 | Q96NT5 | chr17: 28,394,756-28,407,197 |
SLC46A2 | solute carrier family 46 member 2 |
57864 | Q9BY10 | chr9: 112,878,920-112,890,913 |
SLC47A1 | solute carrier family 47 (multidrug and toxin extrusion), member 1 |
55244 | Q96FL8 | chr17: 19,495,385-19,579,034 |
SLC4A2 | solute carrier family 4 (anion exchanger), member 2 |
6522 | P04920 | chr7: 151,057,210-151,076,527 |
SLC4A4 | solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
8671 | Q9Y6R1 | chr4: 71,186,757-71,572,087 |
SLC4A8 | solute carrier family 4, sodium bicarbonate cotransporter, member 8 |
9498 | Q2Y0W8 | chr12: 51,391,317-51,515,763 |
SLC51A | solute carrier family 51 alpha subunit |
200931 | Q86UW1 | chr3: 196,211,487-196,243,178 |
SLC52A3 | solute carrier family 52 (riboflavin transporter), member 3 |
113278 | Q9NQ40 | chr20: 760,080-776,015 |
SLC5A11 | solute carrier family 5 (sodium/inositol cotransporter), member 11 |
115584 | Q8WWX8 | chr16: 24,845,841-24,911,628 |
SLC5A5 | solute carrier family 5 (sodium/iodide cotransporter), member 5 |
6528 | Q92911 | chr19: 17,871,973-17,895,174 |
SLC6A1 | solute carrier family 6 (neurotransmitter transporter), member 1 |
6529 | P30531 | chr3: 10,992,724-11,039,247 |
SLC6A14 | solute carrier family 6 (amino acid transporter), member 14 |
11254 | Q9UN76 | chrX: 116,436,622-116,461,458 |
SLC6A6 | solute carrier family 6 (neurotransmitter transporter), member 6 |
6533 | P31641 | chr3: 14,402,576-14,489,349 |
SLC6A8 | solute carrier family 6 (neurotransmitter transporter), member 8 |
6535 | P48029 | chrX: 153,688,099-153,696,593 |
SLC7A11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
23657 | Q9UPY5 | chr4: 138,164,097-138,242,349 |
SLC7A2 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
6542 | P52569 | chr8: 17,497,088-17,570,573 |
SLC7A5 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
8140 | Q01650 | chr16: 87,830,023-87,869,488 |
SLC7A6 | solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 |
9057 | Q92536 | chr16: 68,264,516-68,301,823 |
SLC7A7 | solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
9056 | Q9UM01 | chr14: 22,773,222-22,829,820 |
SLC7A8 | solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
23428 | Q9UHI5 | chr14: 23,125,295-23,183,674 |
SLC7A9 | solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 |
11136 | P82251 | chr19: 32,830,509-32,869,766 |
SLC9A2 | solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 |
6549 | Q9UBY0 | chr2: 102,619,707-102,711,318 |
SLC9A6 | solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 |
10479 | Q92581 | chrX: 135,973,841-136,047,269 |
SLCO2A1 | solute carrier organic anion transporter family member 2A1 |
6578 | Q92959 | chr3: 133,932,696-134,052,184 |
SLCO2B1 | solute carrier organic anion transporter family member 2B1 |
11309 | O94956 | chr11: 75,100,563-75,206,549 |
SLCO3A1 | solute carrier organic anion transporter family member 3A1 |
28232 | Q9UIG8 | chr15: 91,853,695-92,172,435 |
SLCO4C1 | solute carrier organic anion transporter family member 4C1 |
353189 | Q6ZQN7 | chr5: 102,233,986-102,296,549 |
SLIT2 | slit guidance ligand 2 |
9353 | O94813 | chr4: 20,253,260-20,620,561 |
SMAD3 | SMAD family member 3 |
4088 | P84022 | chr15: 67,063,763-67,195,195 |
SMAD7 | SMAD family member 7 |
4092 | O15105 | chr18: 48,919,853-48,950,711 |
SMAGP | small cell adhesion glycoprotein |
57228 | Q0VAQ4 | chr12: 51,244,558-51,270,890 |
SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 |
64750 | Q9HAU4 | chr17: 64,542,295-64,662,068 |
SNAP23 | synaptosome associated protein 23kDa |
8773 | O00161 | chr15: 42,491,233-42,545,356 |
SNAP25 | synaptosome associated protein 25kDa |
6616 | P60880 | chr20: 10,218,830-10,307,418 |
SNAP29 | synaptosome associated protein 29kDa |
9342 | O95721 | chr22: 20,858,983-20,891,218 |
SNCA | synuclein alpha |
6622 | P37840 | chr4: 89,724,099-89,838,315 |
SNX4 | sorting nexin 4 |
8723 | O95219 | chr3: 125,446,644-125,520,197 |
SNX9 | sorting nexin 9 |
51429 | Q9Y5X1 | chr6: 157,700,387-157,945,077 |
SORBS1 | sorbin and SH3 domain containing 1 |
10580 | Q9BX66 | chr10: 95,311,771-95,561,414 |
SOS1 | SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 | Q07889 | chr2: 38,981,396-39,124,345 |
SP3 | Sp3 transcription factor |
6670 | Q02447 | chr2: 173,906,459-173,965,702 |
SPAM1 | sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding) |
6677 | P38567 | chr7: 123,925,237-123,971,414 |
SPATA20 | spermatogenesis associated 20 |
64847 | Q8TB22 | chr17: 50,543,058-50,555,852 |
SPG20 | spastic paraplegia 20 (Troyer syndrome) |
23111 | Q8N0X7 | chr13: 36,301,638-36,370,180 |
SPHK1 | sphingosine kinase 1 |
8877 | Q9NYA1 | chr17: 76,376,584-76,387,860 |
SPINT2 | serine peptidase inhibitor, Kunitz type, 2 |
10653 | O43291 | chr19: 38,244,035-38,292,614 |
SPPL2A | signal peptide peptidase like 2A |
84888 | Q8TCT8 | chr15: 50,702,266-50,765,808 |
SPPL3 | signal peptide peptidase like 3 |
121665 | Q8TCT6 | chr12: 120,762,510-120,904,371 |
SPRED1 | sprouty-related, EVH1 domain containing 1 |
161742 | Q7Z699 | chr15: 38,252,326-38,357,249 |
SPRY1 | sprouty RTK signaling antagonist 1 |
10252 | O43609 | chr4: 123,396,795-123,403,760 |
SPRY2 | sprouty RTK signaling antagonist 2 |
10253 | O43597 | chr13: 80,335,976-80,340,951 |
SPTBN4 | spectrin, beta, non-erythrocytic 4 |
57731 | Q9H254 | chr19: 40,466,241-40,576,464 |
SRA1 | steroid receptor RNA activator 1 |
10011 | Q9HD15 | chr5: 140,537,340-140,558,252 |
SRP72 | signal recognition particle 72kDa |
6731 | O76094 | chr4: 56,466,915-56,503,680 |
SRPK1 | SRSF protein kinase 1 |
6732 | Q96SB4 | chr6: 35,832,966-35,921,342 |
SSFA2 | sperm specific antigen 2 |
6744 | P28290 | chr2: 181,891,833-181,930,738 |
SSNA1 | Sjogren syndrome nuclear autoantigen 1 |
8636 | O43805 | chr9: 137,188,647-137,190,370 |
SSTR1 | somatostatin receptor 1 |
6751 | P30872 | chr14: 38,207,999-38,213,067 |
SSTR5 | somatostatin receptor 5 |
6755 | P35346 | chr16: 1,078,781-1,080,142 |
STAB1 | stabilin 1 |
23166 | Q9NY15 | chr3: 52,495,338-52,524,495 |
STAB2 | stabilin 2 |
55576 | Q8WWQ8 | chr12: 103,587,273-103,766,727 |
STAMBP | STAM binding protein |
10617 | O95630 | chr2: 73,828,916-73,873,659 |
STAT2 | signal transducer and activator of transcription 2 |
6773 | P52630 | chr12: 56,341,597-56,360,155 |
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 | P40763 | chr17: 42,313,324-42,388,568 |
STAU1 | staufen double-stranded RNA binding protein 1 |
6780 | O95793 | chr20: 49,113,339-49,188,367 |
STEAP4 | STEAP4 metalloreductase |
79689 | Q687X5 | chr7: 88,270,892-88,306,891 |
STIM2 | stromal interaction molecule 2 |
57620 | Q9P246 | chr4: 26,857,678-27,025,381 |
STK17B | serine/threonine kinase 17b |
9262 | O94768 | chr2: 196,133,566-196,176,503 |
STRN3 | striatin 3 |
29966 | Q13033 | chr14: 30,893,799-31,026,401 |
STS | steroid sulfatase (microsomal), isozyme S |
412 | P08842 | chrX: 7,219,456-7,354,810 |
STUB1 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
10273 | Q9UNE7 | chr16: 680,224-682,870 |
STX11 | syntaxin 11 |
8676 | O75558 | chr6: 144,150,526-144,188,370 |
STX2 | syntaxin 2 |
2054 | P32856 | chr12: 130,789,600-130,839,266 |
STX3 | syntaxin 3 |
6809 | Q13277 | chr11: 59,713,456-59,805,882 |
STX4 | syntaxin 4 |
6810 | Q12846 | chr16: 31,032,889-31,042,975 |
STX6 | syntaxin 6 |
10228 | O43752 | chr1: 180,972,712-181,023,121 |
STX7 | syntaxin 7 |
8417 | O15400 | chr6: 132,445,867-132,513,198 |
STXBP1 | syntaxin binding protein 1 |
6812 | P61764 | chr9: 127,579,370-127,696,027 |
STXBP2 | syntaxin binding protein 2 |
6813 | Q15833 | chr19: 7,636,881-7,647,873 |
STXBP5 | syntaxin binding protein 5 (tomosyn) |
134957 | Q5T5C0 | chr6: 147,204,425-147,390,476 |
STXBP5L | syntaxin binding protein 5 like |
9515 | Q9Y2K9 | chr3: 120,908,072-121,424,761 |
STXBP6 | syntaxin binding protein 6 (amisyn) |
29091 | Q8NFX7 | chr14: 24,809,656-25,050,297 |
STYK1 | serine/threonine/tyrosine kinase 1 |
55359 | Q6J9G0 | chr12: 10,618,939-10,674,318 |
SUCLG1 | succinate-CoA ligase, alpha subunit |
8802 | P53597 | chr2: 84,423,523-84,460,045 |
SULF1 | sulfatase 1 |
23213 | Q8IWU6 | chr8: 69,466,624-69,660,915 |
SULF2 | sulfatase 2 |
55959 | Q8IWU5 | chr20: 47,656,348-47,786,616 |
SV2A | synaptic vesicle glycoprotein 2A |
9900 | Q7L0J3 | chr1: 149,903,318-149,917,882 |
SV2B | synaptic vesicle glycoprotein 2B |
9899 | Q7L1I2 | chr15: 91,099,950-91,301,309 |
SVIP | small VCP/p97-interacting protein |
258010 | Q8NHG7 | chr11: 22,813,799-22,830,299 |
SYK | spleen tyrosine kinase |
6850 | P43405 | chr9: 90,801,787-90,898,549 |
SYMPK | symplekin |
8189 | Q92797 | chr19: 45,815,410-45,863,290 |
SYNJ2 | synaptojanin 2 |
8871 | O15056 | chr6: 157,981,887-158,099,176 |
SYT1 | synaptotagmin 1 |
6857 | P21579 | chr12: 78,863,993-79,452,008 |
SYT11 | synaptotagmin 11 |
23208 | Q9BT88 | chr1: 155,859,509-155,885,199 |
SYTL2 | synaptotagmin like 2 |
54843 | Q9HCH5 | chr11: 85,694,224-85,811,159 |
SYTL4 | synaptotagmin like 4 |
94121 | Q96C24 | chrX: 100,674,491-100,732,123 |
SYTL5 | synaptotagmin like 5 |
94122 | Q8TDW5 | chrX: 38,006,582-38,128,819 |
TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
257397 | Q8N5C8 | chrX: 30,827,442-30,975,084 |
TAOK3 | TAO kinase 3 |
51347 | Q9H2K8 | chr12: 118,149,801-118,372,945 |
TAPBPL | TAP binding protein-like |
55080 | Q9BX59 | chr12: 6,451,690-6,466,517 |
TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 |
30851 | O14907 | chr17: 3,662,896-3,668,682 |
TBC1D3 | TBC1 domain family member 3 |
729873 | Q8IZP1 | chr17: 37,977,972-37,989,048 |
TBC1D3C | TBC1 domain family member 3C |
414060 | Q6IPX1 | chr17: 38,057,693-38,068,592 |
TBC1D3D | TBC1 domain family member 3D |
101060389 | A0A087WVF3 | chr17: 38,003,976-38,014,902 |
TBC1D3E | TBC1 domain family member 3E |
102723859 | A0A087X179 | chr17: 37,924,415-37,935,365 |
TBC1D3F | TBC1 domain family member 3F |
84218 | A6NER0 | chr17: 36,428,618-36,439,566 |
TBC1D3H | TBC1 domain family member 3H |
729877 | P0C7X1 | chr17: 36,377,531-36,388,423 |
TCAF1 | TRPM8 channel-associated factor 1 |
9747 | Q9Y4C2 | chr7: 143,851,375-143,902,198 |
TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
10312 | Q13488 | chr11: 68,039,016-68,050,895 |
TDG | thymine DNA glycosylase |
6996 | Q13569 | chr12: 103,965,804-103,988,874 |
TDGF1 | teratocarcinoma-derived growth factor 1 |
6997 | P13385 | chr3: 46,574,534-46,582,463 |
TDP1 | tyrosyl-DNA phosphodiesterase 1 |
55775 | Q9NUW8 | chr14: 89,954,939-90,044,768 |
TECTA | tectorin alpha |
7007 | O75443 | chr11: 121,101,173-121,191,493 |
TEK | TEK tyrosine kinase, endothelial |
7010 | Q02763 | chr9: 27,109,141-27,230,175 |
TENM4 | teneurin transmembrane protein 4 |
26011 | Q6N022 | chr11: 78,652,831-79,440,948 |
TES | testin LIM domain protein |
26136 | Q9UGI8 | chr7: 116,210,493-116,258,783 |
TFPI | tissue factor pathway inhibitor |
7035 | P10646 | chr2: 187,464,230-187,565,760 |
TFRC | transferrin receptor |
7037 | P02786 | chr3: 196,027,183-196,082,189 |
TGFA | transforming growth factor alpha |
7039 | P01135 | chr2: 70,447,280-70,554,193 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TGFBI | transforming growth factor beta induced |
7045 | Q15582 | chr5: 136,028,895-136,063,818 |
TGFBR1 | transforming growth factor beta receptor I |
7046 | P36897 | chr9: 99,104,038-99,154,192 |
TGFBR2 | transforming growth factor beta receptor II |
7048 | P37173 | chr3: 30,606,502-30,694,142 |
THEM4 | thioesterase superfamily member 4 |
117145 | Q5T1C6 | chr1: 151,873,584-151,909,808 |
THSD7A | thrombospondin type 1 domain containing 7A |
221981 | Q9UPZ6 | chr7: 11,370,357-11,832,198 |
TIAM1 | T-cell lymphoma invasion and metastasis 1 |
7074 | Q13009 | chr21: 31,118,416-31,559,977 |
TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein |
114609 | P58753 | chr11: 126,283,065-126,298,845 |
TJAP1 | tight junction associated protein 1 (peripheral) |
93643 | Q5JTD0 | chr6: 43,477,523-43,506,556 |
TJP1 | tight junction protein 1 |
7082 | Q07157 | chr15: 29,699,367-29,968,865 |
TJP2 | tight junction protein 2 |
9414 | Q9UDY2 | chr9: 69,121,264-69,255,208 |
TLCD1 | TLC domain containing 1 |
116238 | Q96CP7 | chr17: 28,724,348-28,727,935 |
TLN1 | talin 1 |
7094 | Q9Y490 | chr9: 35,696,948-35,732,395 |
TLR1 | toll-like receptor 1 |
7096 | Q15399 | chr4: 38,790,677-38,856,817 |
TLR2 | toll-like receptor 2 |
7097 | O60603 | chr4: 153,701,500-153,705,699 |
TLR4 | toll-like receptor 4 |
7099 | O00206 | chr9: 117,704,332-117,716,871 |
TLR5 | toll-like receptor 5 |
7100 | O60602 | chr1: 223,109,406-223,143,282 |
TM7SF3 | transmembrane 7 superfamily member 3 |
51768 | Q9NS93 | chr12: 26,973,195-27,014,434 |
TMED10 | transmembrane p24 trafficking protein 10 |
10972 | P49755 | chr14: 75,131,470-75,176,631 |
TMEFF1 | transmembrane protein with EGF-like and two follistatin-like domains 1 |
8577 | Q8IYR6 | chr9: 100,473,113-100,577,636 |
TMEM198 | transmembrane protein 198 |
130612 | Q66K66 | chr2: 219,543,663-219,550,595 |
TMEM219 | transmembrane protein 219 |
124446 | Q86XT9 | chr16: 29,940,885-29,973,052 |
TMEM47 | transmembrane protein 47 |
83604 | Q9BQJ4 | chrX: 34,627,064-34,657,288 |
TMEM50B | transmembrane protein 50B |
757 | P56557 | chr21: 33,432,485-33,480,011 |
TMEM59 | transmembrane protein 59 |
9528 | Q9BXS4 | chr1: 54,026,681-54,053,504 |
TMEM65 | transmembrane protein 65 |
157378 | Q6PI78 | chr8: 124,306,189-124,372,692 |
TMEM8A | transmembrane protein 8A |
58986 | Q9HCN3 | chr16: 370,773-387,113 |
TMEM97 | transmembrane protein 97 |
27346 | Q5BJF2 | chr17: 28,319,095-28,328,685 |
TMPRSS6 | transmembrane protease, serine 6 |
164656 | Q8IU80 | chr22: 37,065,436-37,109,563 |
TNF | tumor necrosis factor |
7124 | P01375 | chr6: 31,575,567-31,578,336 |
TNFRSF10C | tumor necrosis factor receptor superfamily member 10c |
8794 | O14798 | chr8: 23,084,355-23,117,437 |
TNFRSF11A | tumor necrosis factor receptor superfamily member 11a |
8792 | Q9Y6Q6 | chr18: 62,325,287-62,391,292 |
TNFRSF11B | tumor necrosis factor receptor superfamily member 11b |
4982 | O00300 | chr8: 118,923,557-118,952,200 |
TNFRSF12A | tumor necrosis factor receptor superfamily member 12A |
51330 | Q9NP84 | chr16: 3,018,445-3,022,383 |
TNFRSF19 | tumor necrosis factor receptor superfamily member 19 |
55504 | Q9NS68 | chr13: 23,570,370-23,676,104 |
TNFRSF1B | tumor necrosis factor receptor superfamily member 1B |
7133 | P20333 | chr1: 12,167,003-12,209,228 |
TNFRSF21 | tumor necrosis factor receptor superfamily member 21 |
27242 | O75509 | chr6: 47,231,532-47,309,905 |
TNFRSF25 | tumor necrosis factor receptor superfamily member 25 |
8718 | Q93038 | chr1: 6,461,151-6,466,195 |
TNFSF11 | tumor necrosis factor superfamily member 11 |
8600 | O14788 | chr13: 42,562,736-42,608,013 |
TNFSF13B | tumor necrosis factor superfamily member 13b |
10673 | Q9Y275 | chr13: 108,251,240-108,308,484 |
TNFSF4 | tumor necrosis factor superfamily member 4 |
7292 | P23510 | chr1: 173,183,734-173,207,313 |
TNK2 | tyrosine kinase, non-receptor, 2 |
10188 | Q07912 | chr3: 195,863,364-195,911,945 |
TNS2 | tensin 2 |
23371 | Q63HR2 | chr12: 53,046,969-53,064,372 |
TPCN2 | two pore segment channel 2 |
219931 | Q8NHX9 | chr11: 69,048,897-69,162,440 |
TRADD | TNFRSF1A-associated via death domain |
8717 | Q15628 | chr16: 67,154,180-67,160,298 |
TRAK2 | trafficking protein, kinesin binding 2 |
66008 | O60296 | chr2: 201,377,207-201,451,579 |
TREM1 | triggering receptor expressed on myeloid cells 1 |
54210 | Q9NP99 | chr6: 41,267,926-41,286,719 |
TRH | thyrotropin-releasing hormone |
7200 | P20396 | chr3: 129,974,305-129,977,938 |
TRIB3 | tribbles pseudokinase 3 |
57761 | Q96RU7 | chr20: 362,835-397,559 |
TRIM4 | tripartite motif containing 4 |
89122 | Q9C037 | chr7: 99,876,958-99,919,600 |
TRIM69 | tripartite motif containing 69 |
140691 | Q86WT6 | chr15: 44,728,988-44,767,829 |
TRIP6 | thyroid hormone receptor interactor 6 |
7205 | Q15654 | chr7: 100,867,138-100,873,454 |
TRPC1 | transient receptor potential cation channel, subfamily C, member 1 |
7220 | P48995 | chr3: 142,724,074-142,807,888 |
TRPC3 | transient receptor potential cation channel, subfamily C, member 3 |
7222 | Q13507 | chr4: 121,879,027-121,951,754 |
TRPC6 | transient receptor potential cation channel, subfamily C, member 6 |
7225 | Q9Y210 | chr11: 101,451,564-101,872,562 |
TRPM4 | transient receptor potential cation channel, subfamily M, member 4 |
54795 | Q8TD43 | chr19: 49,157,741-49,211,836 |
TRPM6 | transient receptor potential cation channel, subfamily M, member 6 |
140803 | Q9BX84 | chr9: 74,722,495-74,888,094 |
TRPM7 | transient receptor potential cation channel, subfamily M, member 7 |
54822 | Q96QT4 | chr15: 50,552,473-50,686,815 |
TRPV1 | transient receptor potential cation channel, subfamily V, member 1 |
7442 | Q8NER1 | chr17: 3,565,444-3,609,411 |
TRPV2 | transient receptor potential cation channel, subfamily V, member 2 |
51393 | Q9Y5S1 | chr17: 16,415,542-16,437,003 |
TRPV4 | transient receptor potential cation channel, subfamily V, member 4 |
59341 | Q9HBA0 | chr12: 109,783,085-109,833,401 |
TRPV6 | transient receptor potential cation channel, subfamily V, member 6 |
55503 | Q9H1D0 | chr7: 142,871,203-142,885,762 |
TSPAN14 | tetraspanin 14 |
81619 | Q8NG11 | chr10: 80,454,166-80,533,123 |
TSPAN4 | tetraspanin 4 |
7106 | O14817 | chr11: 842,808-867,116 |
TSPAN5 | tetraspanin 5 |
10098 | P62079 | chr4: 98,470,367-98,658,629 |
TSPYL2 | TSPY-like 2 |
64061 | Q9H2G4 | chrX: 53,082,367-53,088,540 |
TTC17 | tetratricopeptide repeat domain 17 |
55761 | Q96AE7 | chr11: 43,358,932-43,494,933 |
TTC7B | tetratricopeptide repeat domain 7B |
145567 | Q86TV6 | chr14: 90,524,564-90,816,479 |
TTYH1 | tweety family member 1 |
57348 | Q9H313 | chr19: 54,415,219-54,436,900 |
TULP3 | tubby like protein 3 |
7289 | O75386 | chr12: 2,877,223-2,941,140 |
TYROBP | TYRO protein tyrosine kinase binding protein |
7305 | O43914 | chr19: 35,904,401-35,908,295 |
UAP1 | UDP-N-acetylglucosamine pyrophosphorylase 1 |
6675 | Q16222 | chr1: 162,561,506-162,599,842 |
UBA52 | ubiquitin A-52 residue ribosomal protein fusion product 1 |
7311 | P62987 | chr19: 18,571,730-18,577,550 |
UBC | ubiquitin C |
7316 | P0CG48 | chr12: 124,911,604-124,917,368 |
UBE2B | ubiquitin conjugating enzyme E2B |
7320 | P63146 | chr5: 134,371,179-134,391,992 |
UBE2D3 | ubiquitin conjugating enzyme E2D 3 |
7323 | P61077 | chr4: 102,794,383-102,868,896 |
UCHL1 | ubiquitin C-terminal hydrolase L1 |
7345 | P09936 | chr4: 41,256,413-41,268,455 |
ULBP3 | UL16 binding protein 3 |
79465 | Q9BZM4 | chr6: 150,063,150-150,069,095 |
UNC5B | unc-5 netrin receptor B |
219699 | Q8IZJ1 | chr10: 71,212,570-71,302,864 |
UNC5C | unc-5 netrin receptor C |
8633 | O95185 | chr4: 95,162,504-95,549,206 |
UPF3A | UPF3 regulator of nonsense transcripts homolog A (yeast) |
65110 | Q9H1J1 | chr13: 114,281,584-114,305,817 |
UPK3B | uroplakin 3B |
105375355 | Q9BT76 | chr7: 76,510,428-76,516,521 |
USP6 | ubiquitin specific peptidase 6 |
9098 | P35125 | chr17: 5,116,438-5,175,034 |
USP6NL | USP6 N-terminal like |
9712 | Q92738 | chr10: 11,453,946-11,611,754 |
VAMP2 | vesicle associated membrane protein 2 |
6844 | P63027 | chr17: 8,159,149-8,163,546 |
VAMP3 | vesicle associated membrane protein 3 |
9341 | Q15836 | chr1: 7,771,269-7,781,432 |
VAMP7 | vesicle associated membrane protein 7 |
6845 | P51809 | chrX: 155,881,293-155,943,769 |
VAPA | VAMP associated protein A |
9218 | Q9P0L0 | chr18: 9,914,002-9,960,021 |
VAV1 | vav guanine nucleotide exchange factor 1 |
7409 | P15498 | chr19: 6,772,714-6,857,366 |
VAV3 | vav guanine nucleotide exchange factor 3 |
10451 | Q9UKW4 | chr1: 107,571,160-107,965,144 |
VCAM1 | vascular cell adhesion molecule 1 |
7412 | P19320 | chr1: 100,719,742-100,739,045 |
VEZT | vezatin, adherens junctions transmembrane protein |
55591 | Q9HBM0 | chr12: 95,217,746-95,302,790 |
VIM | vimentin |
7431 | P08670 | chr10: 17,228,259-17,237,593 |
VIMP | VCP-interacting membrane selenoprotein |
55829 | Q9BQE4 | chr15: 101,270,817-101,277,500 |
VLDLR | very low density lipoprotein receptor |
7436 | P98155 | chr9: 2,621,834-2,660,053 |
VMP1 | vacuole membrane protein 1 |
81671 | Q96GC9 | chr17: 59,707,192-59,842,255 |
VNN1 | vanin 1 |
8876 | O95497 | chr6: 132,681,590-132,714,049 |
VNN3 | vanin 3 |
55350 | Q9NY84 | chr6: 132,722,787-132,734,765 |
VSTM4 | V-set and transmembrane domain containing 4 |
196740 | Q8IW00 | chr10: 49,014,245-49,115,509 |
WASL | Wiskott-Aldrich syndrome-like |
8976 | O00401 | chr7: 123,681,935-123,749,067 |
WLS | wntless Wnt ligand secretion mediator |
79971 | Q5T9L3 | chr1: 68,098,473-68,233,120 |
WNT2 | wingless-type MMTV integration site family member 2 |
7472 | P09544 | chr7: 117,276,631-117,323,289 |
WNT3 | wingless-type MMTV integration site family member 3 |
7473 | P56703 | chr17: 46,762,506-46,833,154 |
WNT5A | wingless-type MMTV integration site family member 5A |
7474 | P41221 | chr3: 55,465,715-55,490,539 |
WNT5B | wingless-type MMTV integration site family member 5B |
81029 | Q9H1J7 | chr12: 1,529,891-1,647,243 |
WNT6 | wingless-type MMTV integration site family member 6 |
7475 | Q9Y6F9 | chr2: 218,859,821-218,874,233 |
WWP1 | WW domain containing E3 ubiquitin protein ligase 1 |
11059 | Q9H0M0 | chr8: 86,342,738-86,478,420 |
XPC | xeroderma pigmentosum, complementation group C |
7508 | Q01831 | chr3: 14,145,147-14,178,783 |
XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 |
7520 | P13010 | chr2: 216,107,464-216,206,303 |
XRCC6BP1 | XRCC6 binding protein 1 |
91419 | Q9Y6H3 | chr12: 57,941,541-57,957,269 |
XRN1 | 5'-3' exoribonuclease 1 |
54464 | Q8IZH2 | chr3: 142,306,607-142,448,062 |
YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
7533 | Q04917 | chr22: 31,944,461-31,957,603 |
ZBTB16 | zinc finger and BTB domain containing 16 |
7704 | Q05516 | chr11: 114,059,593-114,250,676 |
ZBTB33 | zinc finger and BTB domain containing 33 |
10009 | Q86T24 | chrX: 120,250,752-120,258,398 |
ZDHHC2 | zinc finger, DHHC-type containing 2 |
51201 | Q9UIJ5 | chr8: 17,156,029-17,224,799 |
ZDHHC20 | zinc finger, DHHC-type containing 20 |
253832 | Q5W0Z9 | chr13: 21,372,573-21,459,370 |
ZNF185 | zinc finger protein 185 (LIM domain) |
7739 | O15231 | chrX: 152,914,442-152,973,480 |
ZP1 | zona pellucida glycoprotein 1 |
22917 | P60852 | chr11: 60,867,562-60,875,693 |
ZP3 | zona pellucida glycoprotein 3 (sperm receptor) |
7784 | P21754 | chr7: 76,397,518-76,442,071 |
ZYX | zyxin |
7791 | Q15942 | chr7: 143,381,080-143,391,111 |